Author Archives: admin

Evaluation of Infection Prevention and Control Compliance in Six Referral Hospitals in Tanzania using National and World Health Organization Standard Checklists

DOI: 10.31038/PEP.2021232

Abstract

Background: Tanzania is implementing Infection Prevention and Control (IPC) in health care settings using Standard Based Management and Recognition model. The country has developed standards that are used to assess compliance of IPC best practices in health facilities. In order to compare country’s standards with international standards of IPC achievement, the World Health Organization checklist has been used to assess six hospitals.

Aim: To evaluate the Infection Prevention and Control compliance mean scores by using national Standard Based Management and Recognition tool and WHO’s IPC Assessment Framework at Facility Level (IPCAF – Facility tool).

Methods: A comparative cross-sectional evaluation on IPC compliance using national SBM-R tool and IPCAF Facility (WHO tool) was done in January and May 2020 respectively. We conducted evaluation in six hospitals – four regional referral hospitals (RRHs) namely Bukoba RRH, Maweni RRH, Sekou Toure RRH, Temeke RRH, and two zonal referral hospitals which are Benjamin Mkapa Hospital and Mbeya Zonal Referral Hospital.

Results: Temeke Regional Referral Hospital showed the highest infection prevention and control compliance scores with difference in scores when using SBM-R tool and IPCAF Facility WHO tool of 28 (CI 27.74-28.26) p<0.0001; while the lowest difference mean score was from Sekou Toure RRH, which was 1 (CI 0.74 – 1.26) p<0.0001.

Conclusion: There was a significant difference between the mean scores when evaluation was done using SBM-R tool and the WHO-IPCAF tool in all health care facilities. Generally the scores were average in all cases.

Key words

Infection Prevention and Control, Standards Based Management and Recognition, IPCAF Facility WHO

Background

Compliance with Infection Prevention and Control (IPC) guidelines and standards in low-and middle- income countries (LMICs) continues to be a challenge [1]. This has been attributed to inadequate resources, poor infrastructure and other contextual factors which call for more research to identify approaches that work well in LMICs [2, 3]. Gaps in knowledge of IPC implementation strategies among Nurses in sub-Saharan Africa have been reported mainly on “understanding of which, in what combination, and in what context implementation strategies should be best utilized to ensure their safety and that of their patients” [4]. Analysis of a global situation on implementation of the IPC core components at national level reveal that “most countries have IPC programmes and guidelines, but have not invested adequate resources and neither have they translated them in to implementation and monitoring [5].

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) underscores the need to strengthen IPC practices [2]. Infection Prevention and Control interventions are key in preventing COVID-19 and Healthcare Associated Infections (HAIs). Such interventions include hand hygiene and other hospital- based IPC practices and approaches which are highly required in limited resource settings especially in LMICs [6]. However, a study in the Cochrane Database of Systematic Reviews [7] found variability in certainty of evidence on which approach is better for improving hand hygiene compliance between multimodal and simpler interventions, hence calling for more robust studies. In the area of hand hygiene, Tanzania has been cited as an example of countries in Africa with hand hygiene policies embedded in the IPC policies, i.e., national IPC guidelines, standards and tools [8].

Information available regarding HAIs do not portray the real situation in African countries [9]. Some studies have outlined effective measures which can be implemented in settings where resources are inadequate in order to improve IPC compliance and prevent HAIs. These include developing and implementing policies and procedures on HAIs accompanied with rigorous monitoring and feedback mechanism; and regular education and training of health care workers, patients and visitors on the policies and procedures [10]. A position statement of the International Society for Infectious Diseases in 2020 regarding surveillance of surgical site infections (SSIs) in LMICs noted that the burden of SSIs ranges from 8% to 30% of procedures making it the most common HAI. The statement gives key areas to address in preventing HAIs based on surveillance (collecting valid, high-quality data; linking HAIs to economic incapacity; implementing SSI surveillance within IPC programs; prioritizing IPC training for healthcare workers in LMICs to conduct broad-based surveillance; and developing a highly accurate and objective international system for defining SSIs, which can be translated globally in a straightforward manner) [11].

In October 2015, the world adopted “the 2030 Agenda for Sustainable Development”, in which goal 3 is on “ensuring healthy lives and promoting well-being for all at all ages” with a target (target 3.8) to “achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all” [12]. The target on universal health coverage (UHC) contains, as one of its pillars, the quality aspect which includes IPC. Through the lens of UHC and learning from the COVID-19 pandemic, Karamagi and colleagues have proposed a framework for health systems functionality towards UHC in the WHO African Region in which compliance of standard precautions for IPC is one of proxy indicators for vital sign “patient safety” in the domain “effective demand for essential services” [13]. This puts further emphasis to member states to strengthen compliance of IPC guidelines, standards and tools. Likewise, Storr, et al, (2016) worked to propose key points for building a policy case for IPC in the context of quality UHC as well as support and guidance to national governments. They also described the eight (8) WHO IPC core components [14]. The compliance to the WHO IPC core components in Tanzania in the past two decades is shown in Table 1.

Table 1: Compliance with the WHO- IPC core components in Tanzania: 2004 to 2021

WHO IPC core component (Storr, et al, 2016)  Description of status in Tanzania: 2004-2021
Organisation of IPC Programmes

 

There is a sub-unit responsible for IPC within the Health Quality Assurance Unit at the Ministry of Health, Community Development, Gender, Elderly and Children [32]; with qualified staff with clear roles and responsibilities. Funding for IPC activities comes from Development Partners, Implementing Partners and the Government of Tanzania. Startup IPC programme in 2003 was funded by the US – PEPFAR [33].

 

Technical Guidelines

 

National IPC Guidelines were developed in 2004 (MoH, 2004) and revised in 2018 to accommodate new scientific developments and recommendations by the WHO [17]. IPC standards:hospital standards, 2012; health centre standards, 2015, and dispensary standards, 2015 were revised in 2020 [34]. IPC Communication Strategy was developed in 2012 covering a period of 2012-2017 [3]. Dissemination of the revised guidelines, standards and standard operating procedures is ongoing.
Human Resources Education and Training

 

Training of health care workers has been the main component which included training of Tutors in health training institutions as a way of addressing gaps in pre-service curricula. There are IPC focal persons at health facilities both at regional and council levels. Generally, in the country the ministry had coordinated building the capacity of 2544 healthcare workers on IPC countrywide.
Surveillance of infections and assessment of compliance with IPC practices

 

The Ministry has developed tools to conduct surveillance on Surgical Site Infection (SSI). The tools are already in use in all six health facilities and some other hospitals in the country. The Ministry is also developing Monitoring and Evaluation system for IPC in which surveillance of SSIs is part of.
Microbiology Laboratory

 

Tanzania is complying with the WHO’s recommendations on Antimicrobial Resistance (AMR) interventions. IPC is one of the technical working groups that aimes to address AMR in the country. AMR surveillance is done through laboratories by conducting culture and sensitivity.
Built Environment, Material and Equipment

 

 

In the Ministry, there is an Environmental Health and Sanitation Section responsible for water, sanitation and hygiene (WASH) interventions under Division for Preventive Services. There are guidelines on WASH in health care facilities [36]; and guidelines for supervision of environmental health and sanitation are in place [37]. Patient placement, isolation facilities and storage of sterile
supplies are embedded in the national IPC guidelines, 2018.

Monitoring and Evaluation of programmes Ministry of Health, through the IPC programme, has developed IPC indicator matrix and is currently developing monitoring and evaluation system whereby all health facilities will be required to report on monthly basis.
Multimodal Strategies IPC programme in Tanzania employs multimodal strategies such that various modalities are used to make IPC a continuous practice and agenda in health facilities. Some of the models used are frequent training, mentorships, supervisions,  posters, job aids, and SoPs

The MoHCDGEC, in collaboration with partners reviewed the National IPC Guidelines of 2004 [15] to a new version of 2018. Also, in 2019 the MoHCDGEC reviewed the IPC standards for hospitals, 2012 [16] and updated to a new version [17] that is in line with the revised national guideline, 2018. The MoHCDGEC has also embarked into countrywide dissemination of the revised national IPC guideline (2018) to health facilities [18] in order to improve IPC practices as one of key pillars to fight threats of emerging and reemerging infectious diseases including Ebola Virus Disease (EVD) that had been affecting the neighboring country of the  Democratic Republic of Congo (DRC) [19]; and the recent pandemic of coronavirus disease of 2019 (COVID-19) which is caused by severe acute respiratory Syndrome coronavirus 2 (SARS-CoV-2) that was first reported in Wuhan city of China in December 2019 [20, 21].

In Tanzania, the standard based management recognition (SBM-R) tool has been mainly used to ensure compliance of IPC standards in hospitals [16]. The SBM‐R “consists of systematic utilization of detailed performance standards for rapid and repeated assessments of health facilities, including both clinical and support systems; identification of gaps in compliance with these standards; implementation of corrective interventions; and rewarding of achievements through recognition mechanisms” [22]. Quality Improvement Teams (QITs) are responsible for overall governance of quality improvement issues in hospitals. They provide advice to the Hospital Management Team (HMT) on matters related to quality, and supervise Work Improvement Teams (WITs) in departments [23, 24].

Strengthening compliance of IPC practices in health facilities is of utmost importance in this era of increasing emerging and re-emerging infectious diseases [25, 26]. Emerging and re-emerging diseases are global threats towards human existence. In Tanzania, the trend for emerging and reemerging diseases is increasing; and this is attributed to several factors including changes in ecology, climate and human demographics. Infectious diseases which are on the rise in Tanzania include Cholera, Rift Valley Fever, Plague, Anthrax, Swine Flu, and Dengue [27]. Among the notable emergency events in the country is the Cholera epidemic of August 2015 – July 2017, in which 30,269 cases were reported with 475 deaths (CFR of 1.6%) [28].

Tanzania has been affected by COVID-19 pandemic [29], which is an ongoing crisis all over the world. Moreover, Tanzania remains to be at high risk of EVD as neighboring DRC continues to suffer from repeated outbreaks since 2018 [30]. Hence, the need to implement effective and timely IPC measures is of paramount importance [31].

Tanzania has limited capacity of healthcare staffs in responding to potential infectious disease outbreaks. Also, HAIs prevention systems have not been effectively implemented at health facility levels; and there is limited coordination and collaboration between QITs and Working Improvement Teams (WITs) in addressing HAIs and eventually emerging and re-emerging diseases [23]. Also, in Tanzania the functionality of QITs in RRHs have been demonstrated to be inadequate, which may affect implementation of quality improvement activities [24]. Improving mentorship on prevention of HAIs offers an opportunity for optimal use of the limited resources in reducing of negative impacts on animal and human health. This paper aims at documenting the experience of IPC standards compliance in six hospitals using SBM-R approach and assesses the factors that are responsible for improved functionality of QITs and WITs as well as IPC sub-committee in the hospitals.

Objectives

The overall objective of the study was to gauge compliance with infection prevention and control in six referral hospitals by using National and World Health Organization checklists.

Specifically, the objectives of the study were to:

  • Determine compliance score of IPC Standards using national IPC standards checklist in six referral hospitals;
  • Determine compliance score of IPC Standards using WHO’s IPCAF- tool) in six referral hospitals; and
  • Compare compliance scores between national IPC standards tool and WHO’s IPCAF- tool in six referral hospitals.

Hypothesis

It was hypothesized that mentorship would improve compliance with IPC standards and measures through: (1) strengthening the functionality of quality governance structures (QITs and WITs) by providing members with opportunity for more hands-on practice; (2) building capacity of frontline workers in various departments and wards; and (3) clarification of challenging issues observed during assessments and observations in the service areas. Conceptual framework in the implementation of IPC activities in Tanzania is shown in figure 1.

fig 1

Figure 1: Conceptual framework in implementation of IPC activities in Tanzania (Credit: Bahegwa, R. P. (2021))

Methodology

Study design: A comparative cross-sectional study on IPC compliance using SBM-R tool and IPCAF – Facility WHO tool.

The national SBM-R tool has been used in Tanzania for assessment of IPC [38]. It is structured based on the functional areas within the health care facility like operating theatre, labour ward, etc. The checklist captures all standard and transmission-based precautions of IPC in all functional areas. Each functional area can score a maximum of hundred percent (100%). At the end the facility is assigned average score of all functional areas. The scores assigned are interpreted as follows: 0%-49%-poor:  the facility needs a lot of work to improve; 50%-79%-moderate: needs to improve at some areas; and 80%-100%- acceptable and more investment is needed to sustain the compliance.

The IPCAF – Facility WHO tool was tested using a robust global study (in 46 countries, 181 hospitals and 324 individuals) and revised as necessary and then approved as an effective tool for IPC improvement in healthcare facilities [39]. The assessment of the facility through the use of IPCAF – Facility WHO tool focuses on eight (8) main core components of the IPC namely the IPC programme; IPC guidelines; IPC education and training; HAI surveillance; Multimodal strategies; Monitoring/audits of IPC practices and feedback; Workload, staffing and bed occupancy; and Built environment, materials and equipment for IPC at the facility level) which are then addressed by a total of 81 indicators. These indicators are based on evidence and expert consensus and have been framed as questions with defined answers to provide an orientation for assessment. Based on the overall score achieved in the eight sections, the facility is assigned to one of four levels of IPC promotion and practice: Inadequate (0-200): IPC core components implementation is deficient. Basic, (201-400): Significant improvement is required, some aspects of the IPC core components are in place, but not sufficiently implemented. Further improvement is required. Intermediate (401-600): Most aspects of the IPC core components are appropriately implemented. The facility should continue to improve the scope and quality of implementation and focus on the development of long-term plans to sustain and further promote the existing IPC programme activities. Advanced (601-800): The IPC core components are fully implemented according to the WHO recommendations and appropriate to the needs of the facility.

The assessment using SBM-R tool was conducted in January 2020 and the assessment using WHO’s IPCAF-Facility tool was done in May 2020. Prospective documentation of IPC compliance in the six hospitals – four regional referral hospitals (RRHs) namely Bukoba RRH, Maweni RRH, Sekou Toure RRH, Temeke RRH, and two zonal referral hospitals which are Benjamin Mkapa Hospital and Mbeya Zonal Referral Hospital, was done from January to May 2020.

Target population: All operating referral health care facilities in the country (regional, zonal and national hospitals) regardless of their ownership, i.e. public or private.

Study population: Prospective documentation of IPC implementation in the six hospitals –Bukoba RRH, Maweni RRH, Sekou Toure RRH, Temeke RRH, Benjamin Mkapa Hospital and Mbeya Zonal Referral Hospital, was done. The Assessment using SBM-R tool in those hospitals was followed by implementation of developed action plans by Hospital’s QIT through an IPC Focal Person who chairs an IPC sub-committee that reports to QIT.

Assessment by using the IPCAF – Facility WHO Tool was done in May 2020, as part of efforts to institutionalize IPC skills among the hospital’s IPC sub-committee to oversee IPC implementation. Also, the QITs conducted IPC assessment in the hospital on quarterly basis and the WITs in each department (functional area) conducted assessment in their functional area on monthly basis as part of SBM-R implementation in the respective hospital. In between the assessments, there have been mentorship visit in which IPC standards implementation was assessed using the IPC Hospital Standards Assessment Tool. The mentors worked as facilitators to the QITs, WITs and IPC sub-Committees in helping them to get hands-on knowledge and skills on IPC standards, standard operating procedures, as well as scoring using the tools; which ultimately helped the members of the teams to become champions. Also, qualitative information on the functionality of the QIT, WITs, IPC sub-Committee, as well as Hospital Management Team support to and commitment to IPC practices strengthening was documented, to help understand about possibility of sustaining the teams’ performance [24].

In order to ensure that decisions for strengthening IPC practices both at the facility as well as at national coordination levels are guided by the data collected, both mentors and the QITs and WITs emphasized on the importance of ensuring data quality [40].

Data management and analysis

Data was cleaned and checked for completeness and outliers before analysis. The established scores for compliance of IPC Standards were tested for normality by using the Shapiro Wilk test. We used Wilcoxon Signed-Ranks test for related samples to determine whether there was mean score differences between assessment done using national SBM-R tool and assessment done using IPCAF– Facility WHO Tool [41].

Descriptive statistics, tables and charts were used to summarize the data. Comparison between compliance mean scores between assessments done using the SBM-R tool and IPCAF- Facility WHO Tool were tested by T test; results were considered significant at p < 0.05.

Results

Compliance score of IPC Standards using national IPC standards checklist and IPCAF-Facility WHO tools.

The IPC compliance using the national Tool has revealed 2(33.34%) out of six hospitals had poor compliance of IPC best practices. The remaining 4(66.66%) had moderate compliance. No facility achieved the excellent level; the maximum score of health facilities by using national tool was moderate. Upon using the IPCAF – Facility WHO tool, three hospitals (50.00%) were found to meet the basic compliance level; while two hospitals (33.34%) were on intermediate level and one hospital (16.67%) met the advanced compliance level. The details are shown in figure 2 and table 2 below.

fig 2

Figure 2: Scores of IPC compliance using national IPC SBM-R tool and IPCAF – Facility WHO tool

Table 2: Scores of IPC compliance using national IPC SBM-R tool and IPCAF – Facility WHO tool

SN Health Facility Score of IPC assessment using Hospital IPC SBM-R standards (TZ) 20-24 January 2020  Score of IPC Assessment by using IPCAF -Facility WHO Tool) 18 – 23 May 2020
 1 Bukoba RRH 56% (Moderate) 30% (Basic)
 2 Maweni RRH 28% (Poor) 52% (Intermediate)
 3 Sekou Toure RRH 44% (Poor) 43% (Basic)
 4 Temeke RRH 61% (Moderate) 89% (Advanced)
5 Benjamin Mkapa ZRH 61%(Moderate) 66% (Intermediate)
6 Mbeya ZRH 51%(Moderate) 36% (Basic)

ZRH = Zonal Referral Hospital

Comparison of compliance scores between national IPC standards tool and IPCAF-Facility WHO tool

There was a significant difference between the mean scores done by using national SBM-R tool and IPCAF – Facility WHO tool in all facilities. The details are shown in table 3.

Table 3: Comparison of scores of IPC compliance using national IPC SBM-R tool and IPCAF – Facility WHO tool

Health Facility Scores when using IPC SBM-R tool Score while Using IPCAP WHO tool Difference Score 95% Confidence Interval P-Value
Bukoba RRH 56% 30% 26 24.74-26.26 P < 0.0001
Maweni RRH 28% 52% 24 23.74-24.26 P < 0.0001
Sekou Toure RRH 44% 43% 1 0.74 – 1.1.26 P < 0.0001
Temeke RRH 61% 89% 28 27.74 – 28.26 P < 0.0001
Benjamin Mkapa Hospital 61% 66% 5 4.74%-5.26 P < 0.0001
Mbeya Zonal Referral Hospital 51% 36% 15 14.74-15.26 P < 0.0001

Discussion

General outcome based on both national SBM-R and the IPCAF for facility-WHO tools

Assessment of IPC practices is key to monitor compliance, provide recommendations and hence improve quality of health care services delivery. Our assessments have delivered valuable insights into the state of art on implementation of key IPC structures and processes in Tanzania. Overall, the data gathered demonstrated that IPC is generally at a moderate level as demonstrated from the national SBM-R and IPCAF-Facility WHO tools. However, the use of IPCAF-Facility WHO tool in some areas revealed presence of all score levels: basic, poor and advanced.

Generally moderate level of IPC implementation was expected by both tools, as Tanzania is classified among the lower middle-income countries according to the World Bank classification. Even though, a considerable low number of participating hospitals which were only six (6), four 66.67% were allocated to merely an “intermediate/moderate” IPC level. This rather surprising finding could either be explained by a very strict interpretation of both National and IPCAF tools.

Besides the differences observed among the six participating referral hospitals in Tanzania with regard to the overall national and IPCAF tool scores, we noticed pronounced differences between facility scores of the respective national and IPCAF sections. Scores for Temeke RRH and Benjamin Mkapa were generally high as gauged by both tools. However, specific questions focusing on low scores of IPC compliance revealed mixed results. Maweni RRH scored low by using national SBM-R tool while Bukoba RRH scored low when using IPCAF -Facility tool.

Outcome based on the national SBM-R tool

The national SBM-R tool, which was structured based on standard and transmission-based precautions, was used to assess the following areas: hand hygiene; decontamination; safe waste management; safe handling of sharps; use of PPE; consider every person is potentially infectious and has risk to succumb infection;

These six hospitals did not consider every person (patient/clients or staff) as potentially infectious and susceptible to infection, hence the health care workers considered only those with clinical features as infectious. That was a risk not only to the healthcare workers but also to other patients/clients, community and the environment.

In healthcare settings, healthcare workers are required to use appropriate hand hygiene techniques. In these six facilities the critical moments to practice hand hygiene was not complied as per the requirement of WHO and the MoHCDGEC [42].  This finding compares with the study in Ethiopia which found that only 14.9% of health care providers in Central Gondar zone public primary hospitals, Northwest Ethiopia, had good hand hygiene compliance [43].

In addition to hand hygiene, healthcare workers are required to wear appropriate Personal Protective Equipment (PPE) whenever they provide healthcare services. However, in all the six hospitals visited, adherence was very low. This assessment is in-line with the study by Okello, et al (2017) which was conducted at St. Mary’s Hospital Lacor in Northern Uganda which found that 2% of healthcare workers do not know the purpose of PPE, 23.7% do not know how to don and doff PPEs, 13.6% do not use PPE even when indicated and 10% are not using an appropriate PPE [44].

In terms of management of sharps. healthcare workers in all the six hospitals visited were compliant in handling sharps appropriately. This includes use of sharps only once, avoiding recapping, and safe disposal in the sharp boxes. A study by Tariku, et al (2016) at Gondar University Comprehensive Specialized Hospital, Northwest Ethiopia found that 76.4% never bent needles with hands, 54.3% avoided removing used needles from disposable syringes, 87.2% placed used sharps in puncture-resistant container at point of use and 58.7% never recapped needles [45]. Handling of waste was low in all six facilities which were similar with the findings found at Gondar University Comprehensive Specialized hospital where level of adherence was 30.2% in segregation of noninfectious wastes in black color-coded dust bin, 34.4% in segregation of infectious medical wastes in yellow color-coded dust bin [45]. Appropriate patient management, and maintaining environmental cleanness, (eg. prompt and careful cleaning up spills of blood and other body fluids after the spill event) is also an area which was assessed and found to have fairly lower score in these six facilities which also happen to be similar to findings from Gondar University Comprehensive Specialized hospital which scored 38.3% [45].

In the six hospitals assessed, processing of instrument was good from cleaning to either sterilization or high-level disinfection; and this was consistent with the findings by Tariku and colleagues who reported compliance with sterilization of all reusable equipment before being used on another patient to be 73.7%. However, processing of linen was not following the standards and hence the linen used in these facilities is changing color from white to brown [45].

Cough etiquette to patients, caregivers and visitors with signs and symptoms of respiratory illness improved a lot. This was due to COVID-19 pandemic where all health facilities were implementing IPC and it was mandatory for everyone going to health facilities to wear a mask and observe cough etiquette.

Implementation of pre- and post-exposure prophylaxis (PEP): In Tanzania, the pre-exposure prophylaxis in the context of IPC in health provision setting is not recommended; however, (PEP) is recommended. The score in this area is low in terms of reporting and use of PEP which is comparable to finding by Maria, et al, (2016) in Tanzania that found that out of 357 health care workers who had a blood exposure in the previous 6 months, only 34% reported it and only 58% were offered PEP [46]. Provision of hepatitis B vaccination is the only vaccine which is given as far as the IPC is concerned. The challenges identified during assessment were lack of vaccine in the facilities and some of the health workers did not complete all the three doses, others had one and others had two doses and only a few had completed all the three as per schedule.

Outcome based on the IPCAF for facility-WHO tool

All the six hospitals were found to have IPC programmes/committees in place that are responsible for overseeing the IPC. In Tanzania these teams are QITs and IPC committees. The IPC subcommittee is a subunit of the Quality Teams. These teams were found to be actively supporting the IPC activities. However, doctors were not active and majority were nurses in these six hospitals. The other challenge of these teams is lack of advanced knowledge of IPC as recommended by WHO [47].

According to data from the assessment using IPCAF tool, the six hospitals had on-site trainers for conducting basic IPC training, as almost all hospitals reported having staff capable of performing basic IPC training. However, the trainers of basic IPC training revealed gaps especially with regard to the regularity of training and the understanding of complicated issues of IPC. The importance of consistent IPC training has been demonstrated in various publications, and given the presence of capable staff on-site, appears feasible in Tanzania hospitals [48].

The IPC guidelines were available in all six facilities. Tanzania has revised its IPC national guidelines to align with the WHO guidelines and other international updates. The guidelines have emphasized the emerging and reemerging infections as well as AMR [17]. The challenges concerning the guidelines were that not all functional areas within the health facilities were provided with the guidelines; and those that had the guidelines had limitations in terms of translating them into practice.

All the six hospitals reported documenting HAIs specifically SSIs. The documentation of the SSIs was an early inception of SSIs surveillance given the increase in awareness on the subject, following recommendations from WHO on the burden of HAIs.  We found the area of surveillance to be a big gap in all the six facilities. The data from documentation of SSIs were not analyzed and used in these six facilities as recommended by the WHO [1].

Efforts to strengthen IPC in middle lower-income countries should place emphasis on multimodal strategies [49]. The concept of multimodal strategies is new in Tanzania. Effective implementation of IPC is needed to improve healthcare delivery. However, given the rather low scores obtained by the six hospitals in terms of implementing multimodal strategies in IPC interventions, it appeared that awareness for and implementation of multimodal strategies were not yet fully achieved.

Monitoring/audits of IPC practices and feedback is the area which scored lowest in all facilities. In Tanzania, the QITs /IPC teams are required to do internal assessment, supervision and mentorship. In these six facilities neither monitoring/audits of IPC practices and feedback nor assessments, supervisions and mentorships were done.

No health facility among the six hospitals had achieved standard workload, staffing and bed occupancy. As in many other sub-Saharan African countries, the ratio of healthcare staff to patients, staff work load, and bed occupancy are significantly below standard.

In the hospitals assessed, beds are arranged less than one meter apart and, in some wards, one bed was occupied by more than one patient.

These six hospitals have built environment, materials and equipment for IPC at the facility level though not at the level that national and international standards would require. However, the facilities had ongoing improvement strategy so as to attain the required standards.

Conflict of Interests

There were no conflicts of interest amongst authors.

Disclaimer

The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.

References

  1. Rasa, K. and Kilpatrick, C (2020) Implementation of World Health Organization Guidelines in the Prevention of Surgical Site Infection in Low- and Middle-Income Countries: What We Know and Do Not Know. Surg Infect (Larchmt) Sep;21(7):592-598. doi: 10.1089/sur.2020.163. http://doi.org/10.1089/sur.2020.163 Epub 2020 Jun 1. PMID: 32478641. [crossref]
  2. Sadler, S.J. and Fuller, A.T. (2020) Reframing infection control approaches in low-resource healthcare settings: A nod to the emic perspective. Journal of Global Health 10(2): 020340 (5 pages).[Online Publication Date: 11 August 2020]. Available at: http://www.jogh.org/documents/issue202002/jogh-10-020340.htm Accessed on 03 April, 2021. [crossref]
  3. Sastry, S., Masroor, N., Bearman, G., Hajjeh, R.,   Holmes, A., Memish, Z., et al. (2017) The 17th International Congress on Infectious Diseases workshop on developing infection prevention and control resources for low- and middle-income countries. International Journal of Infectious Diseases 57:138-143. DOI: https://doi.org/10.1016/j.ijid.2017.01.040 [crossref]
  4. Barrera-Cancedda, A.E., Riman, K.A., Shinnick, J.E., et al. (2019) Implementation strategies for infection prevention and control promotion for nurses in Sub-Saharan Africa: a systematic review. Implementation Sci14,  DOI: https://doi.org/10.1186/s13012-019-0958-3 [crossref]
  5. Tartari, E., Tomczyk, S., Pires, D.,   Zayed, B.,  Coutinho Rehse, A.P.,  Kariyo, P.,    Stempliuk, V.,     Zingg, W.,     Pittet,    and Allegranzi, B (2021) Implementation of the infection prevention and control core components at the national level: a global situational analysis. Journal of Hospital Infection 108:94-103. https://doi.org/10.1016/j.jhin.2020.11.025
  6. Cobb, N., Papali, A., Pisani, L., Schultz, M.J. and  Ferreira, J.C., (2021) for the COVID-LMIC Task Force and the Mahidol-Oxford Research Unit (MORU). Pragmatic Recommendations for Infection Prevention and Control Practices for Healthcare Facilities in Low- and Middle-Income Countries during the COVID-19 Pandemic. J. Trop. Med. Hyg 104(Issue 3_Suppl):25–33. doi:10.4269/ajtmh.20-1009. https://doi.org/10.4269/ajtmh.20-1009 [crossref]
  7. Gould, D.J., Moralejo, D., Drey, N., Chudleigh, J.H. and Taljaard, M. (2017) Interventions to improve hand hygiene compliance in patient care. Cochrane Database of Systematic Reviews Issue 9, Art. No.: CD005186. DOI: 10.1002/14651858.CD005186.pub4. https://doi.org/10.1002/14651858.CD005186.pub4  Accessed 20 March 2021. [crossref]
  8. Loftus, M.J., Guitart, C., Tartari, , Stewardson, A.J., Amer, F., Bellissimo-Rodrigues, F., et al. (2019) Hand hygiene in low- and middle-income countries. International Journal of Infectious Diseases 86: 25–30. DOI: https://doi.org/10.1016/j.ijid.2019.06.002 [crossref]
  9. Sengupta, S., Barman, P. and Lo, J (2019) Opportunities to Overcome Implementation Challenges of Infection Prevention and Control in Low-Middle Income Countries. Curr Treat Options Infect Dis11, 267–280. DOI: https://doi.org/10.1007/s40506-019-00200-w
  10. Manchanda, V., Suman, U. and Singh, N (2018) Implementing Infection Prevention and Control Programs When Resources Are Limited. Curr Treat Options Infect Dis10, 28–39. DOI: https://doi.org/10.1007/s40506-018-0142-3
  11. Mehtar, S., Wanyoro, A., Ogunsola, F., Ameh, E.A., Nthumba, P., Kilpatrick, C., et al. Implementation of Surgical Site Infection Surveillance in Low- and Middle-Income Countries A Position Statement for the International Society for Infectious Diseases. 
    International Journal of Infectious Diseases (IF 3.202 ) Pub Date : 2020-07-24 , DOI: 1016/j.ijid.2020.07.021  [crossref]
  12. United Nations General Assembly. 70/1. Transforming our world: the 2030 Agenda for Sustainable Development. Seventieth session Agenda items 15 and 116. A/RES/70/1 Resolution adopted by the General Assembly on 25 September 2015 [without reference to a Main Committee (A/70/L.1)] Distr.: General 21 October 2015. Available at: https://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E Accessed on 05th April, 2021.
  13. Karamagi, H.C., Tumusiime, P., Titi-Ofei, R., et al. (2021) Towards universal health coverage in the WHO African Region: assessing health system functionality, incorporating lessons from COVID-19. BMJ Global Health 6:e004618. doi:10.1136/ bmjgh-2020-004618 Available at: https://gh.bmj.com/content/6/3/e004618 Accessed on 03April, 2021. [crossref]
  14. Storr, J., Kilpatrick, C., Allegranzi, B. and Syed, S.B. (2016) Redefining infection prevention and control in the new era of quality universal health coverage. Journal of Research in Nursing 21(1):39-52. DOI: 1177/1744987116628328
  15. Ministry of Health. National Infection Prevention and Control Guidelines for Healthcare Services in Tanzania. (November 2004) Dar es Salaam, The United Republic of Tanzania. Available at: at/wzNQV Accessed on 04th April, 2021.
  16. Ministry of Health and Social Welfare. National Infection Prevention and Control Standards for Hospitals in Tanzania. Standards-Based Management and Recognition for Improving Infection Prevention and Control Practices – An Assessment Tool, 2012. Dar es Salaam, The United Republic of Tanzania. Available  at: at/isvK1 Accessed on 04th April 2021.
  17. Ministry of Health, Community Development, Gender, Elderly and Children. National Infection Prevention and Control Guidelines for Health care Services in Tanzania (June, 2018). Dodoma, The United Republic of Tanzania.
  18. Management Science for Health. (2020) Fiscal Year 2020 Quarter 1 (October–December 2019) Report. USAID Medicines, Technologies, And Pharmaceutical Services (MTAPS) Program. Available at: https://www.msh.org/sites/default/files/mtaps_fy20q1_quarterly_report_final.pdf Accessed on 05th May, 2021.
  19. World Health Organization (2018)  Tanzania launches training for national rapid response teams with focus on Ebola. WHO – United Republic of Tanzania, Available at:  https://www.afro.who.int/news/tanzania-launches-training-national-rapid-response-teams-focus-ebola Accessed on 05th May 2021.
  20. AdnanShereen, M., Khan, S.,   Kazmi, A., et al  (2020) COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research 24 (2020): 91–98. https://doi.org/10.1016/j.jare.2020.03.005 [crossref]
  21. Fauci, A.S., Lane, H. C. and Redfield, R.R. (2020) Covid-19 — Navigating the Uncharted. Engl J Med 382(13):1268-1269. DOI: 10.1056/NEJMe2002387. Available at: https://www.nejm.org/doi/full/10.1056/nejme2002387 Accessed on 05th April, 2021.
  22. Necochea, E., Tripathi, V., Kim, Y-M., Akram, N., Hyjazi, Y., da Luz Vaz, M., et al. (2015). Implementation of the Standards-Based Management and Recognition approach to quality improvement in maternal, newborn, and child health programs in low-resource countries. International Journal of Gynaecology and Obstetrics 130:S17-S24. DOI: http://dx.doi.org/10.1016/j.ijgo.2015.04.003 [crossref]
  23. Ministry of Health and Social Welfare (2011). The Tanzania Quality Improvement Framework in Health Care (2011–2016), October, 2011. Dar es Salaam, Tanzania. Available at: at/auFJK Accessed on 05th May 2021.
  24. Kacholi, G. and Mahomed, O.H. (2020). Sustainability of quality improvement teams in selected regional referral hospitals in Tanzania. International Journal for Quality in Health Care, mzaa032, DOI: https://doi.org/10.1093/intqhc/mzaa032 [crossref]
  25. Branch-Elliman, W., Price, C.S., Bessesen, M.T. et al. (2015) Using the Pillars of Infection Prevention to Build an Effective Program for Reducing the Transmission of Emerging and Reemerging Infections. Curr Envir Health Rpt2, 226–235. DOI: https://doi.org/10.1007/s40572-015-0059-7 [crossref]
  26. Weber, D.J., Sickbert-Bennett, E.E., Kanamori, H. and Rutala, W.A. (2019). New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility. American Journal of Infection Control 47:A29−A38. DOI: https://doi.org/10.1016/j.ajic.2019.03.004 [crossref]
  27. Devaux, C.A. (2012) Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks. World J Virol 1(1):11-22. DOI: https://dx.doi.org/10.5501/wjv.v1.i1.11 [crossref]
  28. World Health Organization Regional Office for Africa. Weekly Bulletin on Outbreaks and other Emergencies. Week 31: 29 July-04 August 2017. Data reported by 17:00; 04 August 2017. Available at: http://apps.who.int/iris/bitstream/handle/10665/258688/OEW31-2970482017.pdf?sequence=1 Accessed on 30th April, 2021
  29. World Health Organization Regional Office for Africa. Weekly Bulletin on Outbreaks and other Emergencies. Week 22: 25 -31 May 2020. Data as reported by: 17:00; 31 May 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/332246/OEW22-2531052020.pdf Accessed on 30th April, 2021.
  30. World Health Organization Regional Office for Africa. Weekly Bulletin on Outbreaks and other Emergencies. Week 16: 12-18 April, 2021.Data as reported by: 17:00; 18 April, 2021. Available at: https://apps.who.int/iris/bitstream/handle/10665/340903/OEW16-1218042021.pdf Accessed on 30th April, 2021.
  31. Mangu, C. D., Manyama, C. K., Msila, H., Sudi, L., Chaula, G., Ntinginya, N. E., Sabi, I., and Maboko, L. (2016). Emerging viral infectious disease threat: Why Tanzania is not in a safe zone. Tanzania Journal of Health Research 18(3). https://doi.org/10.4314/thrb.v18i3.
  32. President’s Office – Public Service Management and Good Governance (PO-PSMGG). The Approved Functions and Organization Structure of The Ministry of Health, Community Development, Gender, Elderly and Children (Approved by the President on 7th July, 2018). July, 2018. Dodoma, The United Republic of Tanzania. Available at: at/uNW24 Accessed on 04th April, 2021.
  33. Fauci, A.S. and Eisinger, R.W. (2018) PEPFAR – 15 Years and Counting the Lives Saved. N Engl J Med 378(4):314-316. DOI: 1056/NEJMp1714773. PMID: 29365298. [crossref]
  34. Hokororo, J., Eliakimu, E., Ngowi, R., et al. (2021) Report of Trend for Compliance of Infection Prevention and Control Standards in Tanzania from 2010 to 2017 in Tanzania Mainland. Microbiol Infect Dis 5(3): 1-10. Available at: https://scivisionpub.com/pdfs/report-of-trend-for-compliance-of-infection-prevention-and-control-standards-in-tanzania-from-2010-to-2017-in-tanzania-mainland-1598.pdf Accessed on 04th April, 2021.
  35. Ministry of Health and Social Welfare. National Communication Strategy for Infection Prevention and Control 2012 – 2017. (December 2012). Dar es Salaam, The United Republic of Tanzania. Available at: at/oSVX6 Accessed on 04th April, 2021.
  36. Ministry of Health, Community Development, Gender, Elderly and Children. The National Guidelines for Water, Sanitation and Hygiene in Health Care Facilities (October, 2017). Environmental Health and Sanitation Section, Directorate of Preventive Services, Dodoma, The United Republic of Tanzania. Available at: https://www.moh.go.tz/en/guidelines?start=60 Accessed on 04th April, 2021.
  37. Ministry of Health, Community Development, Gender, Elderly and Children (July, 2020). National Environmental Health, Sanitation and Hygiene Supervision Guidelines. Environmental Health and Sanitation Section, Directorate of Preventive Services, Dodoma, The United Republic of Tanzania. Available at: https://www.moh.go.tz/en/guidelines?start=10 Accessed on 04th April, 2021.
  38. Ministry of Health, Community Development, Gender, Elderly and Children (August 2020). National IPC Standards for Hospitals in Tanzania.
  39. Tomczyk, S., Aghdassi, S., Storr, J., Hansen, S., Stewardson, A.J., Bischoff, P., Gastmeier, P. and Allegranzi, B (2020) Testing of the WHO Infection Prevention and Control Assessment Framework at acute healthcare facility level. J Hosp Infect 105(1):83-90. DOI:https://doi.org/10.1016/j.jhin.2019.12.016 Epub 2019 Dec 21. PMID: 31870887. [crossref]
  40. Wagenaar, B.H., Hirschhorn, L.R., Henley, C. et al.(2017). Data-driven quality improvement in low-and middle-income country health systems: lessons from seven years of implementation experience across Mozambique, Rwanda, and Zambia. BMC Health Serv Res 17, 830 (2017). DOI: https://doi.org/10.1186/s12913-017-2661-x [crossref]
  41. World Health Organization (2018) Infection Prevention and Control Assessment Framework at the Facility Level. https://www.who.int/infection-prevention/tools/core-components/IPCAF-facility. Accessed on 21st May 2021
  42. World Health Organisation, 2009. WHO Guidelines on Hand Hygiene in Health Care: a Summary. https://www.who.int/gpsc/5may/tools/who_guidelines-handhygiene_summary.pdf. Accessed on 22nd April 2021
  43. Garedew Tadege EngdawMulat GebrehiwotZewudu Andualem (2019) Hand hygiene compliance and associated factors among health care providers in Central Gondar zone public primary hospitals, Northwest Ethiopia. https://aricjournal.biomedcentral.com/. Accessed on 22nd April 2021. [crossref]
  44. R Okello1, Kansime2 , J Odora3 , J A Apio4 , I Pecorella (2017) Barriers and Factors Affecting Personal Protective Equipment Usage in St. Mary’s Hospital Lacor in Northern Uganda. https://dx.doi.org/10.4314/ecajs.v22i1.8. Accessed on 23rd April 2021.
  45. Tariku Gebre Haile, Eshetu Haileselassie Engeda, and Abdella Amano Abdo (2016) Compliance with Standard Precautions and Associated Factors among Healthcare Workers in Gondar University Comprehensive Specialized Hospital, Northwest Ethiopia. https://downloads.hindawi.com/journals/jeph/2017/2050635.pdf. Accessed on 23rd April 2021. [crossref]
  46. Maria LahuertaDejana SelenicGetachew KassaGoodluck MwakitoshaJoseph HokororoHenock NgonyaniSridhar V BasavarajuCari Courtenay-QuirkYang LiuKoku KazauraDaimon SimbeyeNaomi Bock, et al. (2016) Reporting and case management of occupational exposures to blood-borne pathogens among healthcare workers in three healthcare facilities in Tanzania. https://doi.org/10.1177%2F1757177416645343. Accessed on 24th April 2021.
  47. World Health Organization. (2018). Leadership and programme management in infection prevention and control. https://www.who.int/infection-prevention/tools/core-components/advanced-training-leadership.pdf? Accessed on 21st May 2021.
  48. Constantinos T., Gabriel B., Erik B.Aleksander DLenny ten H.Enrique C. et (2020) Education and training programmes for infection prevention and control professionals: mapping the current opportunities and local needs in European countries. https://aricjournal.biomedcentral.com/ Accessed on 22nd April 2021. [crossref]
  49. Kritsotakis, E. orcid.org/0000-0002-9526-3852, Astrinaki, E., Messaritaki, A. et al. (2018) Implementation of multimodal infection control and hand hygiene strategies in acute-care hospitals in Greece: a cross-sectional benchmarking survey. American Journal of Infection Control. ISSN 0196-6553 https://doi.org/10.1016/j.ajic.2018.04.217. Acessed on 22nd April 2021.

Travelers’ Diarrhea in the Era of COVID-19

Abstract

The COVID 19 pandemic started as a cluster of unexplained pneumonia in Wuhan, China and till now more than 111 million cases have been reported. Due to stringent public health measures, including lockdown strategies, the international travels were tremendously reduced. Hopes rise for end of pandemic as Corona virus vaccinations proved to have high efficacy and the true real-world effectiveness is estimated to be very good. International travels will probably start and the many safety issues should be remembered and emphasized for all travelers and any destination. The most predictable and avoidable travel related illness is infectious diarrhea that may be reduced by simple measures as are hand hygiene, food and water safety and less by antibiotic use or other pharmacologic options.

Keywords

Traveler’s diarrhea, Guidelines, Antibiotics

The COVID-19 pandemic forced tourism to shift from the global to an idyllic local pattern within country’s borders but the Coronavirus vaccination strategies applied all over the world bring the expectation for less travel restrictions.

Travelers’ diarrhea (TD) was the most predictable travel-related illness with rates (30-70%) depending on destination, season, adventurous eating or sexual practices and resulting in unpleasant holiday, hospitalization and eventually prolonged recovery mainly in immunosuppresed patients [1-3].

The etiology is dominated by bacteria (80%-90%), less by viruses and protozoa. Guidelines are published in the Yellow Book by CDC, the International Society of Travel Medicine, providing relevant data, clinical evidence and consensus statements [2,3]. Diarrhea often occurs abruptly and is accompanied by abdominal cramping, fever, nausea, or vomiting. The previous severity definitions based on the number of unformed stools per day were revised by using the relevant criteria of functional impact. This therapeutic approach depending on severity, safety and the effectiveness of treatment classifies TD in: mild (acute diarrhea that is tolerable, is not distressing, and does not interfere with planned activities), moderate (acute diarrhea that is distressing or interferes with planned activities) and severe (acute diarrhea that is incapacitating or completely prevents planned activities). Acute severe diarrhea also includes dysentery (grossly bloody stools) and persistent diarrhea (lasting>2 weeks) [3].

The main exposures, epidemiological entities and etiologies are expressed as:

  • Foodborne outbreaks associated with many food items [noroviruses, nontyphoidal Salmonella, Clostridium perfringens, Bacillus cereus, Staphylococcus aureus, Campylobacter spp, coli pathotypes (enteroaggregative, enterotoxigenic, enteroinvasive), Listeria, Shigella, Yersinia, Cyclospora cayetanensis, Cryptosporidium spp, hepatitis A virus],
  • Waterborne (drinking or swimming) – Campylobacter, Cryptosporidium, Giardia, Shigella, Salmonella, STEC, Plesiomonas shigelloides,
  • Travel to resource-challenged countries – coli (enteroaggregative, enterotoxigenic, enteroinvasive), Shigella, Typhi and nontyphoidal Salmonella, Campylobacter, Vibrio cholerae, Entamoeba histolytica, Giardia, Blastocystis, Cyclospora, Cystoisospora, Cryptosporidium) [3,4].

Any traveler should be advised about the probable exposures, food, water safety and hygiene, and informed about individual and other population consequences related to the travel (dissemination of antimicrobial resistance), the self assessment of disease severity and treatment [3,5].

High-risk destinations (TD incidence >20%) include Africa (exception of South Africa), South and Central America, South and Southeast Asia, Mexico, Haiti, and the Dominican Republic, intermediate-risk destinations (TD incidence 8 to < 20%) include Southern and Eastern Europe, Central and East Asia (including China and Russia), the Middle East (including Israel), South Africa, and Caribbean Islands and low-risk destinations (TD incidence < 8%) include North America, Northern and Western Europe, Australia, New Zealand, Singapore, and Japan [1,6]. Foodborne outbreaks may occur in well developed countries affecting local population and travelers as it happened in Spain in 2019, Listeria monocytogenes was linked to the consumption of domestically produced chilled pork roast from a single manufacturer in the municipality of Sevilla [7].

The incubation period is short for viruses and bacteria (6-72 hours) and much longer for intestinal parasites (1-3 weeks). Untreated bacterial diarrhea usually lasts 3-7 days, viral diarrhea 2-3 days and parasitic enteritis lasts a couple of weeks. Usually, the microbiologic testing is not necessary except for persistent or severe diarrhea in returning travelers (strong recommendation, low/very low level of evidence). Molecular testing may confirm frequent or rare etiologies when needed [2-4]. Klem et al. found that the most frequent long term complication is postinfectious irritable bowel syndrome, 41.9% after enteritis caused by parasites and protozoa, and 13.8% after bacterial infection [8].

There were many studies and meta-analyses upon prophylaxis and treatment options in TD with the conclusion that antibiotics are not to be considered routinely in mild and moderate acute diarrhea [2,3]. No vaccines are available for common enteric pathogens causing TD, except for cholera and typhoid fever. Live attenuated cholera vaccines are recommended to adults, as a single dose given orally with a good efficacy (90% at 10 days and 80% at 3 months). The vaccines are not recommended to immunosuppressed patients, except for asplenic patients or those having chronic kidney disease. The commonly used typhoid fever vaccine is an inactivated Vi capsular polysaccharide vaccine given intramuscularly, in children ≥ 2 years and adults with an efficacy of 50-80%, the booster dose can be given after 2 years after primary vaccination. Both vaccines are recommended only for travelers to high risk regions, unconventional itineraries and housing (Table 1) [2].

Table 1: Treatment options in TD diarrhea [2,3].

Treatment

Grade Practice Recommendation/Level of Evidence

Acute mild diarrhea 1. Oral rehydration (sealed beverages).

2. Antibiotics are not recommended.

3. Self treatment may be considered with Loperamide* or bismuth subsalicylate (BSS)**.

2, 3. Strong recommendation, moderate level of evidence
Acute moderate diarrhea 1. Oral rehydration [sealed beverages, oral rehydration solution (ORS) if dehydration is severe].

2. Loperamide may be considered for use as monotherapy or adjunctive therapy.

3. Antibiotics may be used: azithromycin, fluoroquinolones, rifaximin.

2. Strong recommendation, high level of evidence.

3. Weak recommendation, moderate level of evidence.

Acute severe diarrhea 1. Oral or parenteral rehydration.

2. Antibiotics should be used.

3. Azithromycin is preferred.

4. Fluoroquinolones or rifaximin may be used.

2. Strong recommendation, high level of evidence.

3. Strong recommendation, moderate level of evidence.

4. Weak recommendation, moderate level of evidence.

*Loperamide, 4 mg (2 mg/tb), as soon as possible then 2 mg after each lost stool, maximum 12 mg/day. Not recommended for children <12 years, in febrile or bloody diarrhea [9].
**BSS 524 mg (262 mg/tb) every 30 minutes to 1 hour as needed (maximum of 8 doses/24 hours). Not recommended for children <12 years, pregnant women, travelers taking aspirine or methotrexate [10,11].

Antibiotics in TD

  • Azithromycin may be used to treat moderate TD and should be used in severe TD as a single dose regimen (1,000 mg) or two doses of 500 mg 12 hours apart (better tolerated) or 500 mg/day for 3 days (if no resolution in 24 hours). It is the preferred regimen for invasive and febrile diarrhea and in regions where there are suspected or demonstrated fluoroquinolone resistant coli pathotypes and Campylobacter. Can be given to pregnant women and children.
  • Fluoroquinolones (orally) may be used in moderate noninvasive TD and less in severe TD (weak recommendation, moderate level of evidence). There is some evidence about the emergence of antimicrobial resistance and the risk of dysbiosis beyond the well-known musculoskeletal adverse events that makes the benefit/risk ratio doubtful. Levofloxacin may be used as a single dose of 500 mg or in a 3 day course, ciprofloxacin 750 mg as a single dose or 500 mg in a 3 day course and ofloxacin 400 mg as a single dose or in a 3 day course. The 3 day course is considered when symptoms persist > 24 hours [3,4].
  • Rifaximin may be used in non-invasive moderate and severe TD (weak recommendation, moderate level of evidence). Rifaximin is not recommended in invasive TD (Campylobacter, Salmonella, Shigella, invasive coli). Since it is a non-absorbable oral antibiotic, the safety profile is excellent. In TD rifaximin is given as 200 mg three times daily for three days [9-12].

Antibiotic regimens may be combined with loperamide because the anti-motility action is the fastest then completed by the curative antibiotic treatment and there are no more adverse effects with the combined strategy [3,9]. Doxycycline might be recommended for malaria prophylaxis and was associated with lower TD risk, suggesting bacterial enteropathogen susceptibility similar to previous observations and additional benefit in infection prevention [13].

Some studies showed higher rates of extended-spectrum β-lactamase producing Enterobacteriaceae (ESBL-E) if combined therapy (loperamide and antibiotic) was used in TD [3,14]. Arcilla et al. found that the most important predictors for the acquisition of ESBL-E during international travel were: antibiotic use during travel (adjusted odds ratio 2.69, 95% CI 1.79-4.05), persistent TD after return (2.31, 1.42-3.76), and pre-existing chronic bowel disease (2.10, 1.13-3.90) [5]. Ghandi et al. evaluated the patterns of empiric antibiotic self-treatment in international travelers from US using 31 Global TravEpiNet (GTEN) sites (Centers for Disease Control and Prevention sponsored consortium of clinics that provide pretravel health consultations). Between 2009 and 2018 the rate of antibiotic prescription declined steadily from >75%, mainly for fluoroquinolones showing that doctors and travelers are less prone to antibiotic treatment or prevention [15].

TD Prevention

Beyond hand hygiene, sanitation and food safety recommendations, antimicrobial prophylaxis is not routinely considered in international travelers (strong recommendation, low/very low level of evidence) being prescribed only for travelers at high risk of health-related complications of TD (strong recommendation, low/very low level of evidence). The most commonly recommended antibiotic is rifaximin which has an excellent safety profile [3,4,12].

BSS (two tabs 4 times a day) may be used for prophylaxis and can reduce the incidence of travelers’ diarrhea by almost half, though it should be avoided in children and pregnant women due salicylate side effects (strong recommendation, high level of evidence) [3,10,11]. Regarding probiotics and prebiotics there is insufficient evidence to recommend their use as preventive or treatment measure in TD. A recent systematic Cochrane review found that probiotics may not affect the duration of diarrhea [16].

Foodborne and waterborne infections, may be severe in immunocompromised people. Travelers with liver disease should avoid direct exposure to salt water that may expose them to Vibrio spp., and all immunocompromised hosts should avoid raw seafood. Drug interactions should be evaluated before considering antibiotic prophylaxis or self treatment. Fluoroquinolones and rifaximin have significant interactions with antiviral HIV treatment. Macrolides may have significant interactions with antiviral HIV medication and transplant-related immunosuppressive drugs. Fluoroquinolones and azithromycin in combination with calcineurin inhibitors and mTor inhibitors (tacrolimus, cyclosporine, sirolimus, everolimus) may cause prolonged QT interval [2].

With or without COVID-19 vaccine passports, probably more and more people will travel all over the world in the next years needing protection for the most frequent unpleasant event during the travel, TD. Somehow, a blessing in disguise, the COVID-19 pandemic imposed the highest hygiene rules and probably lower rates of infectious diarrhea in international travelers will be observed.

Author Contributions

Concept and writing of the manuscript (A.R.). The author approved the final version of the manuscript.

Funding

No external financial support was received.

Conflict of Interest

Nothing to declare for the author.

References

  1. Steffen R, Hill DR, DuPont HL (2015) Traveler’s diarrhea: a clinical review. JAMA 313(1):71-80. [crossref]
  2. Centers for Disease Control and Prevention. CDC Yellow Book 2020: Health Information for International Travel. New York: Oxford University Press.
  3. Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, et al. (2017) Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. J Travel Med 24(suppl_1):S57-S74. [crossref]
  4. Shane AL, Mody RK, Crump JA, et al. (2017) Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 65(12):1963-1973. [crossref]
  5. Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MCJ, van Genderen PJJ, et al. (2017) Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis 17(1):78-85. [crossref]
  6. LaRocque R, Harris J.B. Travelers’ diarrhea: Microbiology, epidemiology, and prevention.
  7. European Centre for Disease Prevention and Control, European Food Safety Authority, 2019. Multi-country outbreak of Listeria monocytogenes sequence type 6 infections linked to ready-to-eat meat products – 25 November 2019.
  8. Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, et al. (2017) Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology 152:1042–1054. [crossref]
  9. Dunn N., Chika N. Okafor. Travelers Diarrhea. [crossref]
  10. Brum JM, Gibb RD, Ramsey DL, Balan G, Yacyshyn BR (2020) Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea. Dig Dis Sci, [crossref]
  11. Budisak P, Abbas M (2020) Bismuth Subsalicylate. StatPearls Publishing, [crossref]
  12. Robertson KD, Nagalli S (2020) Rifaximin. StatPearls Publishing, [crossref]
  13. Lago K, Telu K, Tribble D, Ganesan A, Kunz A, et al. (2020) For The Infectious Disease Clinical Research Program TravMil Study Group. Doxycycline Malaria Prophylaxis Impact on Risk of Travelers’ Diarrhea among International Travelers. Am J Trop Med Hyg 103(5):1864-1870. [crossref]
  14. Kantele A, Mero S, Kirveskari J, Lääveri T (2016) Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea. Emerg Infect Dis 22(1):117-120. [crossref]
  15. Gandhi AR, Rao SR, Chen LH, Nelson MD, Ryan ET, et al. (2020) Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers’ Diarrhea in Global TravEpiNet, 2009–2018, Open Forum Infectious Diseases, [crossref]
  16. Collinson S, Deans A, Padua-Zamora A, Gregorio GV, Li C, et al. (2020) Probiotics for treating acute infectious diarrhoea. Cochrane Database of Systematic Reviews, Art. No.: CD003048. [crossref]

Retrospective Google Trends Analysis to Evaluate Possible COVID-19 Outbreak Onset in Italy

Abstract

Background: Due to the delayed communication by Chinese authorities and International bodies, it is difficult to settle when COVID-19 pandemic has started. Italy has been the first country outside Asia to experience the spreading of SARS-CoV-2 among general population, but it is possible that some patients had already developed the infection, before the first Italian official case was confirmed at the end of February.

Methods: We have performed a specific analysis from 1st August 2019 to 29th February 2020 on Google Trends, which is a publicly available tool that compares the volume of Internet searches concerning specific queries in different areas and periods. The analysis was retrospectively extended up to 5-years in order to study the seasonality of Google Trends’ search volumes in relation to potential COVID-19 symptoms.

Results: Our analyses concerning researchers on the Internet support the evidence that the outbreak onset in Italy could be set some weeks before the first confirmed case, maybe before flights closure between Italy and China imposed at the end of January 2020.

Conclusions: Internet-acquired data might represent a preliminary real-time surveillance and alert tool for healthcare systems to plan the most appropriate responses in case of health emergency such as COVID-19 pandemic.

Keywords

COVID-19; Symptoms; Internet; Web; Searches; Google trends

Introduction

The huge amount of searches run through Google creates trends data that can be analyzed by a specific function named “Google Trends” (GT), a publicly available tool that compares the volume of Internet searches concerning specific queries in different areas and periods [1]. Individuals affected by any clinical condition frequently use search engines, such as Google, to look for terms related to their diseases, possible causes and symptoms [2]. In this view, Google Trends can provide indirect approximations of the burden and symptoms of several diseases, so that they have been used for preliminary epidemiological surveillance purposes [2]. Google Trends can integrate and lead up to traditional surveillance systems in early stage detection of seasonal or annual outbreaks of infectious (i.e. influenza, scarlet fever, HIV) and non-infectious (i.e. cancer, epilepsy) diseases, presenting specific search patterns in different parts of the world [2].

Google Trends had positively been associated with the disease prevalence in many COVID-19 studies [3]. Accordingly, researchers hypothesized that this kind of “digital epidemiology” could come up with valuable insights into the spread of viral infections. We have specifically applied this methodology to evaluate the onset of COVID-19 outbreak in Italy, the first country in Europe to experience the spreading of coronavirus SARS-COV2. Italy was also the first country to impose a nationwide lockdown since Wuhan outbreak (February, 2020). Several clinical and epidemiological studies have been presented on the prevalence of COVID-19, but it is possible that some patients had already developed the infection although it was not specifically diagnosed before the first official case, confirmed in Italy at the end of Febraury [4]. Overall, the coronavirus activity has been associated with specific seasonal patterns in relation to other viral diseases such as influenza [3]. The aim of this work was to predict, through Google Trends, the amount of searches referring to COVID-19 related symptoms in Italian population that can be inferred from Internet-based searching before the first COVID-19 confirmed case in an Italian native patient.

Materials and Methods

We have used the publicly available tool “Google Trends” to determine the amount of searches concerning COVID-19 related symptoms from March 2015 to August 2020 performed by Italian users of Google engine. Search queries were ranged simultaneously into three blocks (most common, less common and severe) as listed by WHO [5]. The search was performed in Italian language to take into account only data belonging to people living in Italy. The first block was related to ‘most common symptoms’ and included: fever (in Italian: ’febbre’), tiredness (in italian: ’spossatezza’), and dry cough (in italian: ’tossesecca’). The second block concerned ‘less common symptoms’ corresponding to: rash(in italian: ’eruzione cutanea’), taste (in italian: ’gusto’), headache (in italian: ’mal di testa’), sore throat (in italian: ’mal di gola’), smell (in italian: ’olfatto’). The third block concerning ‘severe symptoms’ included: loss of voice (in italian: ‘afasia’), chest pain (in italian: ’dolore al petto’), muscles pain (in italian: ’dolori muscolari’), shortness of breath (in italian: ’fiatocorto’) [5,6].

Google Trends tool uses a fraction of searches for a specific term (‘keyword’ or ‘search term’) and automatically standardizes the data for the total number of searches gradually presenting them as comparative search volumes (ranging from 0 to 100), in order to compare variations of different search terms across time series and queries (topics in which the word was searched) [2]. Search volumes about COVID-19 symptoms were extracted from July 2015 to August 2020. The selection of the retrospective 5-years did not represent a random selection as it is bound by the extraction limits of the GT tool. Indeed, trends for periods equal or less than 5 years, are collected by days. This method allows for greater evidence than the monthly-based analysis. Scores, recorded per each day, are based on the absolute search volume for each term and day, being related to the absolute search volume on Google on the same day. Subsequently, GT was adjusted for the annual rate variation (provided by Italian Institute for Statistics, ISTAT) for the age groups showing the highest probability to use Internet (14-74 years old). Thus, for statistical purposes, the terms were aggregated by mean estimator to assess researches concerning COVID-19 ‘most common’, ‘less common’, and ‘severe’ symptoms performed by Italian Internet users.

The study includes three statistical analyses:

  1. Main Analysis: the primary objective was to assess the amount of searches referring to COVID-19 related symptoms that can be present in Italian population before the first COVID-19 officially confirmed case in Italy;
  2. Exploratory analysis: the objective was to assess the peak of terms related to COVID-19 symptoms during the pandemic period;
  3. Adherence analysis: the objective was to assess the extent to which the Internet user’s research behavior corresponded to Google trends queries related to the COVID-19 symptoms.

Main Analysis

As main analysis, an interrupted time series analysis (ITS) was used to examine the effect of coronavirus on Google searches for terms describing symptoms potentially related to COVID-19. Google Trends data were seasonally adjusted and analyzed by using auto-regressive integrated moving average (ARIMA) modelling. The implementation of the exposition was very clear with a ban on searches of symptoms terms throughout Italy across six months from August 2019 (estimated time when the virus was circulating yet) to February 2020 (the month before the first COVID-19 confirmed case in Italy, which actually occurred at the end of February) . As “control group”, we used Internet-based searches that presented the same characteristics of the exposures during continuous period (from March 2015 to July 2019), in order to evaluate the trend changes to the breaking point (F-value test). A model stratified by calendar months was adopted to control seasonality effects. The method includes a bootstrap model by default, which runs 250 replications of the main model with randomly drawn samples. A trimmed mean F-value (10 percent removed) is reported and a boot strapped p-value was derived from it. As exploratory analysis, a generalized linear models (GLM) was adapted to assess the trend peaks of epidemics.

Exploratory Analysis

The exploratory analysis was performed to study the seasonality of Google Trends’ search volume in Italy about potential COVID-19 from August 2019 to August 2020, and evaluate possible differences in relative search volumes for ‘most common’, ‘less common’ and ‘severe’ symptoms across different months, adjusted by years and during the last year since the pandemic. According to the date of the first infected with COVID-19 in Wuhan, the month of December 2019 was considered as reference month. The results were presented as rate ratio and 95% confidence intervals (CIs). Finally, cycle plots were built to show the GLM results and their monthly trends. The vertical positions of the inserted subseries plots indicate the average searches per month. The subseries plot was made up considering monthly trends fit of the y-variable (response variable) and its confidence band; the horizontal axis shows the mean y-value over the considered time interval.

Adherence Analysis

An adherence score, stratified by symptoms’ type, was provided to describe the degree to which Internet users correctly searched terms matching the study topic. The score was computed as the total of the queries that met the study objective on the total of the queries for each type of symptoms (ex: researches related to the ‘superenalotto’ topic are considered not adhering to the objective of the study).

SAS and R studio software have been used for data processing and statistical analyses. Results have been considered statistically significant if p<0.05.

Results

The results are presented in three sub-sections (Most common symptoms, Less common symptoms, Serious symptoms). Then the main analysis and the exploratory analysis are described for each category of symptoms:

Most Common Symptoms

The ‘most common’ symptoms had a positive and significant variation in the exposure group (Internet users’ searches from 1st August 2019 to 29th February 2020) than the control group (p<0.001; F-value=1.69). The Google Trends plot of key terms from February 2018 to April 2019 versus search volumes from February 2019 to April 2020 showed how the interest was considerably higher during the COVID-19 pandemic compared to the peak of previous annual flu outbreak (Figure 2A).

The exploratory analysis (under α=0.05)–performed using as reference the month of December, 2019 adjusted by year–showed a significant increased probability from 2019 to 2020 concerning the search volumes in January 2020 (p=0.018;OR=1.67; CI=1.09-2.55), February 2020 (p=0.003;OR=1.91; CI=1.26-2.91), March 2020 (p=0.002; OR=1.96, CI=1.29-2.99), June 2020 (p=0.007; OR=1.78; CI=1.68-2.71) and July 2020(p=0.008; OR=1.75; CI=1.15-2.67), and confirmed the peak between the end of February 2020 and the beginning of March 2020 (Figure 1A).

Less Common Symptoms

The ‘less common’ symptoms showed a positive and significant variation in the exposure group (users research from 1st August 2019 to 29th February 2020) than the control group (p<0.001; F-value=1.63). The Google Trends plot of key terms from February 2018 to April 2019 versus search volumes from February 2019 to April 2020 showed how the interest was considerably higher during the COVID-19 pandemic compared to the peak of previous year flu outbreak (Figure 2B).

The exploratory analysis (under α=0.05)-performed using as reference the month of December 2019 adjusted by year-showed a significant decreasing probability from 2019 to 2020 concerning the search volumes in January 2020(p=0.005; OR=0.62; CI=0.39-1.00), April 2020 (p=0.034; OR=0.60; CI=0.37-0.96), May 2020 (p=<0.001; OR=0.38; CI=0.22-0.65), June 2020 (p=<0.001; OR=0.32, CI=0.19-0.56) and July 2020 (p=<0.001; OR=0.34; CI=0.19-0.58) and reported the peak between the end of February and the beginning of March 2020 (Figure 1B).

Severe Symptoms

The ‘severe’ symptoms showed a positive and significant variation in the exposure group (Internet users’ searches from August 2019 to February2 020) than the control group (p<0.001; F-value=0.54). The Google Trends plot of key terms from February 2018 to April 2019 versus search volumes from February 2019 to April 2020 showed how the interest was considerably higher during the COVID-19 pandemic compared to the peak of previous year flu outbreak (Figure 2C).

The exploratory analysis (under α=0.05) performed using as reference month December 2019adjusted by year, showed a significant increased probability from 2019 to 2020 concerning the search volumes in February (p=0.048; OR=1.34; CI=1.00-1.78), March 2020(p=<0.001; OR=1.82, CI=1.31-1.54) and April 2020 (p=0.018; OR=1.42; CI=1.06-1.91) and reported the peak between the end of February 2020 and the beginning of March 2020 (Figure 1C).

fig 1

Figure 1: Cycle plot by monthly average GT search for Most common symptoms (A), Less common symptoms (B) and Serious symptoms (C). *Subseries shows the spline fit of search terms in each month.

fig 2

Figure 2: Interrupted time series of GT search for Most common symptoms (A), Less common symptoms (B) and Serious symptoms (C).

Discussion

In the last decade, growing evidence has been made available that Google Trends analyses may be a reliable tool for providing estimates of awareness about many diseases and treatments, which are parallel to real-world epidemiology of diseases and drug use data. This study is the first analysis concerning web search behaviours related to the coronavirus outbreak, both in quantitative and qualitative terms, aimed at assessing the time of COVID-19 onset in Italy. Additional objective of the study was to evaluate and possibly validate the epidemiological reliability of Google Trends in different non-clinical settings, for less common, most common and severe symptoms attributable to COVID-19.

Our findings confirmed how the virus may have been spreading in Italy some weeks before the first Italian native case was officially detected. Indeed, the GT symptom terms potentially related to COVID-19 (based on 250 bootstrap simulations) increased significantly in the exposure group (searches performed from 1st August 2019 to 29th February 2020) compared to the control group (users’ trends of the 5-year time series). Moreover, Google Trends for ‘less common’ ‘and ‘most common’ symptoms presented higher significant association (F-value=1.68 and 1.63, respectively) than severe symptoms (F-value=0.58) considering the exposures as reference group (August 2019 to February 2020). The reasons of these differences could be explained by the fact that ‘common’ terms (such as ‘less’ and ‘most’) considered in this analysis represent a kind of basic noisy as they are very similar to flu-like symptoms than terms used in searches concerning severe ones (such as loss of voice, chest pain, muscles pain and shortness of breath). It is also possible that the virus was initially carried by one or more people with negligible symptoms (mostly related to ‘most common’ and ‘less common’ GT term symptoms) some weeks before the outbreak.

The exploratory analysis of the results reinforces the thesis that the virus could be present in Italy several weeks before the lockdown (March 5th 2020): the ‘less common’ symptoms are more significant in the month of December 2019 than March 2020, which appears to be the peak of the pandemic (Figure 1). As highlighted in other studies [7,8], the ‘less common’ symptoms, such as loss of taste and loss of smell, are the most frequent clinical symptoms (about 90% of cases) in COVID-19 patients. Very recently, a young football player living nearby Lodi (the city where the first official Italian native case was coming from) has been proposed as the possible first documented case, as he showed SARS-COV-2 antibodies (identified on subsequent serum analyses) and severe COVID-related symptoms requiring admission to Intensive Care Unit at the beginning of February 2020, namely three weeks before the hospital admission of the first official Italian native case.

Furthermore, the temporal distribution of web-data seems consistent with the clinical trend of the pandemic: relative search volumes for ‘less common’ (Figure 2A), ‘most common’ (Figure 2B) and ‘severe’ symptoms (Figure 2C) in the period 2019-2020 were positively associated and presented a similar monthly sinusoidal pattern as previously shown in clinical studies evaluating the COVID-19 spread in Italy [9]. This was in line with the trend of hospitalizations in Italy recorded in the same months [9]. Also the spreading of the coronavirus by number of infections in the months of June, July and August 2020 is estimated to be higher than December 2019 (Figure 1B).

Nevertheless, our study has some limitations: the main one is that search volumes of Google Trends are frequently found to be increased in case of conditions with large media coverage or, at least, during periods characterized by a higher burden of disease, so that they are gaining attractivity in surveillance studies on several epidemiologically relevant diseases [10]. This is the case, for example, of coronavirus symptoms, which were the focus of large media coverage in the last months. Another limitation could be that search trends might be produced by people other than patients with COVID-19, who are nevertheless interested about this topic. Furthermore, available data are clearly limited to Google users, and are related to the possibility to use a computer with Internet access, as well as by computer literacy and skills. Therefore, a non-representative sampling bias might have occurred due to different factors, such as age, disability, income or preferred search engine [11]. To overcome this problem, the adherence analysis confirms the consistency between the terms analyzed in the study and the topics related to Covid-19. Google Trends queries related to the terms analyzed during the exposure period were highly adherent to the objective of the study (Table 1: ‘most common’ score=91.9; ‘less common’ score=82.4; ‘severe’ score=91.9). Despite this, in some cases, search biases may be found such as in the case of fever, sore throat, headache, loss of smell or taste and loss of voice (Table 1).

Table 1: Adherence scores of Google trends queries by types and terms related to COVID-19 symptoms during the exposure period (August 2019 to February 2020).

Type

Term Query* Query Rate StudyObjective Adherence Score
Most Common

Fever

Influenza 2020 sintomi

High Yes

91,9%

Influenza 2020 durata

High Yes
Codici superenalotto la febbre del sabato sera High

No

Influenza senz afebbre 2020

High Yes
Dopo quanto tempo fa effetto la tachipirina High

Yes

Tiredness

spossatezza cause

60%

Yes

Drycough

Selentus sciroppo tosse secca

High Yes

Sedativo tossesecca

130%

Yes

Tossesecca e grassa

90% Yes
Aereosoltossesecca 70%

Yes

Sciroppo per tossesecca

60%

Yes

Less Common

Rashon skin

Eruzionecutanea o rash High

Yes

82,4%

Taste

Perditaolfatto e gusto 100%

Yes

Hedache

Mal di testa elodie

High No
Mal di testa pre ciclo High

Yes

Mal di testa tutti i giorni 160%

Yes

Tachipirina 1000

130% Yes
Svegliarsi con il mal di testa 130%

Yes

Sore throat

Nenuco mal di gola

High No
Okitask High

Yes

Rimedio naturale mal di gola

180%

Yes

Rimedi naturali per il mal di gola

110% Yes
Mal di gola e raffreddore 100%

Yes

Smell

Smell

100% Yes
Olfatto 86%

Yes

Smelltraduzione 19%

No

Perditaolfatto

8% Yes
Olfattocane 5%

Yes

Severe

Lossofspeach

Afasiasinonimo

High

No

91,9%
Afaisa primaria progressiva 200%

Yes

Afasia motoria

180%

Yes

Chestpain

Dolore in mezzo al petto

130% Yes
Dolere al petto cause 60%

Yes

Dolore petto e schiena

40%

Yes

Muscules pain

Tachipirina dolori muscolari 70%

Yes

Shortnessofbreath

Fiato corto cause

100% Yes
Fiato corto e tosse 83%

Yes

Fiato corto cuore 65%

Yes

Conclusions

This study provides additional evidence for seasonality of COVID-19 by using Google Trends. In light of our results, we have proposed a method for the right use of Google Trends to predict the pandemic’s trend. This method can serve as a baseline standard to ensure methodological understanding and reproducibility for researchers who choose to use the tool in the future for other countries or regions. In fact, a future approach could be to compare the results between countries or regions and investigate possible correlations with environmental conditions [11]. Internet-acquired data might represent a preliminary real-time surveillance tool and an alert for the care systems to plan the most appropriate resources in specific periods in case of health emergency such as epidemics or pandemics [2]. However, our results support the evidence that the beginning of the outbreak in Italy were probably seeded weeks before the first detection and possibly before the first COVID-19 patient detected and also before the flights closure between Italy and China were suspended at the end of January 2020. As a future perspective, COVID-19 related to Google Trends might be validated with external clinical data sets.

Author Contributions

Conceptualization, A.F. and P.P.; methodology, A.F.; software, A.F.; validation, P.A., P.P. and M.C.; formal analysis, A.F.; investigation, A.F.; resources, A.M.; data curation, P.P.; writing—original draft preparation, A.F and P.P.; writing—review and editing, G.I.; visualization, P.A.; supervision, A.M.; project administration, A.M.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Nuti SV, Wayda B, Ranasinghe I (2014) The use of Google Trends in health care research: a systematic review. PLoS ONE, e109583. [crossref]
  2. Freyer Dugas A, Jalalpour M, Gel Y (2013) Influenza Forecasting With Google Flu Trends. PLoS ONE, [crossref]
  3. Walker A, Hopkins C, Surda P (2020) Use of Google Trends to investigate loss-of-smell-related searches during the COVID-19 outbreak2020. Int Forum Allergy Rhinol 839-847. [crossref]
  4. Porcheddu R, Rubino S (2020) Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries 125-128. [crossref]
  5. Guo Y, Yan Y (2020) The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak – An Update on the Status. Mil Med Res [crossref]
  6. Ciaffi J, Meliconi R (2020) Google trends and COVID-19 in Italy: could we brace for impact?. Intern Emerg Med 1-5.
  7. Lopez J, Cummins S (2018) The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol 2082-2093. [crossref]
  8. Lee Y, Min P (2020) Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J Korean Med Sci, e174. [crossref]
  9. Distante C, Piscitelli P, Miani A (2020) Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy. Int J Environ Res Public Health [crossref]
  10. Nuti , S.V, Wayda B, Ranasinghe I (2013) The Use of Google Trends in Health Care Research: A Systematic Review. PLoS ONE, e109583. [crossref]
  11. Setti L, Passarini F (2020) Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence. Int J Environ Res Public Health 2986. [crossref]

Co-occurring HIV Risk Behaviors among Males Entering Jail

Abstract

People going through the United States (US) criminal justice system often exhibit multiple behaviors that increase their risk of HIV infection and transmission. This paper examined the pattern of co-occurring HIV risk behaviors among male jail detainees in the US. We conducted multivariate analyses of baseline data from an HIV intervention study of ours, and found that: [1] cocaine use, heroin use and multiple sexual partners; and [2] heavy drinking and marijuana were often co-occurring among this population. From pairwise analyses, we also found that [1] heroin and IDU [2] unprotected sexes with main, with non-main, and in last sexual encounter were mostly co-occurring behaviors. Further analyses of risk behaviors and demographic characteristics of the population showed that IDU were more prevalent among middle ages (30-40) and multiple prior incarcerations, and having multiple sex partners was more prevalent among young males younger than 30 years, African American race, and those with low education. Our findings suggest that efficient interventions to reduce HIV infection in this high-risk population may have to target on these behaviors simultaneously and be demographically adapted.

Keywords

HIV risk, Co-occurring behaviors, Correctional facilities, Male jail detainees

Introduction

Over seven million people passed through the criminal justice system in the United State (US) in year 2012 [1]. Among this population, it was estimated that about 2% was infected with HIV including those unaware of their infection [2-4] — as a contrast, the prevalence among the US adult population is around 0.3% according to the US Centers for Disease Control and Prevention (CDC). The prevalence of HIV infection within jails and prisons was estimated to be about 3 to 6 times higher compared with that among non-incarcerated populations [4-8].

The reasons for this increased burden of HIV among populations in correctional settings are multi-factorial and include increased rates of substance abuse, mental illness, poverty and health disparities [9]. Persons who interact with the criminal justice system may be disenfranchised from health services in the community, such as screening programs. That makes the time of incarceration an important public health opportunity to provide HIV prevention and testing services and linkage to care [10-12].

The time period preceding incarceration has been shown to be characterized by increased substance use and risky sexual behaviors that increased exposure to HIV, viral hepatitis, and other transmitted diseases [13-18]. Release from correctional facilities might also be a time of high-risk of acquiring or spreading infections as persons re-entered their communities and resumed risk behaviors [19-21]. Thus, correctional-based HIV counseling and testing programs and prevention interventions may help to decrease their risk behaviors following release from the correctional environment and therefore reduce new HIV infections in this as well as the general population.

Although studies have documented prevalent (direct and indirect) HIV risk behaviors before entering jail (including heavy drinking, substance abuse, sexual promiscuity, and unprotected sex) [19-26] there is limited understanding of the interrelationships among these risk factors. To effectively target prevention interventions to persons at the greatest risk of HIV infection among this population, it is critically important to understand their risk profiles and quantify which risk behaviors are more likely to co-occur. In this paper, co-occurring behaviors are defined as behaviors that occur within certain time period (e.g. a 3 months window) and not necessarily always in the same episode (i.e. concurrently). This definition is consistent with the need of broader interventions on behaviors that are predictive of (not necessarily determinative of) each other and jointly place an individual at a higher risk of HIV infection.

In this paper, we conducted a secondary analysis of data from a study on HIV counseling and testing in jail [27]. Specifically, we used the baseline data of the study to investigate: 1) whether certain risk behaviors were co-occurring and to what extent, and 2) whether risk behaviors were prevalent among people with certain demographic characteristics.

Methods

Prior Study and Data

We previously conducted a two-arm randomized study [27] to assess HIV risk behaviors among males entering the Rhode Island Department of Corrections (RIDOC) jail and compared the efficacy of two methods of HIV counseling and testing (conventional versus rapid HIV testing) with respect to reducing post-release HIV risk behaviors. A total of 264 HIV-negative males met the study enrollment criteria, provided the written informed consent, were recruited within 48 hours of incarceration, and completed the study. The study was approved by the Miriam Hospital institutional review board, the Rhode Island Department of Corrections (RIDOC) Medical Research Advisory Group, and the Office for Human Research Protections of the Department of Health and Human Services. More details of the study are available elsewhere [27].

In this paper, we focused on data that were collected at the baseline of the study, including demographic information and self-reported HIV risk behaviors during 3 months prior to incarceration. The self-reported risk behaviors were collected using a written quantitative behavioral assessment survey on participant’s recent drinking, substance use behaviors (cocaine use, heroin use, marijuana use, injection of any drug) and sexual behaviors (multiple sexual partners, unprotected sex at last sexual encounter, unprotected sex with main partner, and unprotected sex with non-main partner). Because only data at the baseline prior to intervention randomization were used in this paper, we did not distinguish study participants by their study arms.

Statistical Analyses

We conducted three sets of statistical analyses, outlined as follows:

Analysis I

The co-occurrence of two risk behaviors (pair-wise analysis) was assessed using logistic regressions where one behavior (Behavior 1) was used as the dependent variable, and the other behavior (Behavior 2) as an predictor variable. The results are shown in Table 1. All regressions were adjusted for the following demographic covariates: age (categorized as <25; 25 ∼ 30; 30 ∼ 40; and > 40 years), race (Caucasian; Black; Hispanic; others), number of prior incarcerations (dichotomized at median: < 7; ≥ 7), length of incarceration as severity index of crime leading to incarceration (<2 wks; 2 wks ∼ 1/2 yr; > 1/2 yr), and education (did not finish high school; otherwise).

Table 1: Pair-wise association among risk behaviors.

table 1

(a) The table is not symmetric because the analyses are adjusted for the following covariates as predictors of Behavior 1: age, race, prior incarcerations, length of incarceration, and education.
(b) The numbers in parentheses are sample sizes.
(c) Bold indicates a p-value < 0.05 and italic < 0.10.

Pair-wise co-occurring risk behaviors were quantified using odds ratios (ORs), where an OR > 1 (OR < 1) suggests that the existence of one behavior was predictive of the existence (or absence) of the other behavior.

We used the available complete data for assessing risk behaviors, so the analysis sample size varied (range: 73-256 as in Tables 1 and 2). The overall missing data on risk behaviors were moderate (<5%), if we did not count systematic missingness as missing values (e.g. Missing sexual behaviors for those without sexual partner). Throughout, we made the missing at random (MAR) assumption [28]; that is, we assumed that with the same demographic profile, those who provided complete answers to the baseline questionnaire had engaged in similar risk behaviors as those who did not [29].

Table 2: Multivariate analyses of co-occurring risk behaviors.

table 2

(a) The table is not symmetric because the analyses are adjusted for the following demographic covariates: age, race, prior incarcerations, length of incarceration, and education.
(b) The numbers in parentheses are sample sizes.
(c) Bold indicates a p-value < 0.05 and italic < 0.10.
(d) *** “Unprotected sex at last sexual encounter” is not included as a predictor variable in the model.

Analysis II

Multiple co-occurring risk behaviors were assessed using multivariate logistic regressions where one risk behavior (Behavior 1) was used as the dependent variable and other behaviors (Behaviors 2) as predictor variables. The results are shown in Table 2. Similar to Analysis I, the co-occurring of Behavior 1 with other behaviors was characterized by ORs, which have similar interpretations except that the ORs in Table 2 are conditional ORs after accounting for all other behaviors of (Behaviors 2). Again, all analyses were adjusted for the same set of demographic characteristics as in Analysis I. When heavy drinking, cocaine, heroin, marijuana and multiple sexual partners were used as dependent variables, we excluded the risky behaviors ‘unprotected sex with main partner’ and ‘unprotected sex with non-main partner’, because they only applied to subsets of study participants with sexual partners and including them would reduce the sample size by half and reduce the analysis power. When ‘unprotected sex with main partner’ and ‘unprotected sex with non-main partner’ were used as the dependent variables, ‘unprotected sex at last sexual encounter’ was excluded from predictor variables because the later behavior strongly correlated with the former behaviors and therefore overwhelmed the associations of the former two behaviors with other risk factors. IDU was excluded from the analysis because the prevalence of injection drug use was low (overall 8%) leading to sparse data for multivariate analysis and unreliable estimates due to collinearity of heroin use and IDU [30].

Analysis III

Further, we examined the associations between HIV risk behaviors and various demographic characteristics using logistic regressions, where each risk behavior was used a dependent variable and predictor variables included: age, race, the number of prior incarcerations, length of incarceration as severity index of crime leading to incarceration, and education. The predictor variables were categorized in the same way as in Analyses I and II. The associations of each risk behaviors and certain demographic profiles were characterized by ORs.

Data were extracted and prepared using Access 2003 [31]. All analyses were conducted using the statistical program R [32]. Analysis lack of fit was assessed using Hosmer-Lemeshowtests. Statistical significance was set at a p-value < 0.05.

Results

Among the 264 male HIV-negative participants, the median age was 30 years (range 18-65); the majority was Caucasian (52% Caucasian, 22% Black, 14% Hispanic, 12% others); 51% did not finish high school; and the median number of lifetime incarcerations was 6 (range 1-200). Within the prior 3 months before incarceration, 103 (39%, data not available (NA) = 1) were heavy drinkers; 27 (10%, NA = 1) used heroin; 100 (38%, NA = 1) used cocaine; 161 (61%, NA = 1) used marijuana; and 22 (8%, NA = 1) had injected any type of drug. For the same time period, 203 (77%) had a main sexual partner and of those 170 (84%, NA = 1) never used a condom; 111 (42%) had a non-main sexual partner and of those 37 (36%, NA = 3) never used a condom; 81 (31%) had both main and non-main sexual partners; 61 (26%, NA = 4) had multiple (≥ 3) recent sexual partners; and 233 (90%, NA = 4) did not use a condom at last sexual encounter.

In Analysis I, cocaine use was found to be highly predictive of heroin use (OR = 5.21 with a 95% confidence interval (CI) of 1.8-15), IDU (OR = 6.65, CI = 1.9-23), and multiple sexual partners (OR = 2.45, CI = 1.1-5.3); see Table 1. Heroin use and IDU were mostly co-occurring, suggesting that injection might be the preferred route of heroin use. Heavy drinking and marijuana use were predictive of each other (OR = 2.88, CI = 1.6-5.3). Participants who had unprotected sex with their main and non-main sexual partner(s) were more likely to have unprotected sex at last sexual encounter (OR = 25.7, CI = 9.1-73.0 and OR = 88.6, CI = 15-200, respectively). Notably, unprotected sex with main partner and with non-main partner(s) was likely to co-occur (OR = 6.43, CI = 1.56-78.8). In terms of protective behaviors, participants who reported IDU and those with multiple sexual partners were found to be more likely to use condoms at “the last sexual encounter”, though this finding was marginally statistically insignificant (p-values = 0.08 and 0.07, respectively).

In Analysis II, we found that (1) cocaine use, heroin use, and multiple sexual partners, and (2) heavy drinking and marijuana use were mostly co-occurring (Table 2). Heavy drinking and marijuana use were highly predictive of each other (OR = 3.40, CI = 1.7-7.1). Cocaine use was predictive of heroin use (OR = 9.20, CI = 2.7-38.7) and multiple (≥ 3) sexual partnerships (OR = 2.56; CI = 1.1-6.0).

The analyses that examined the relationships between risk behaviors and demographic characteristics (Analysis III) showed that male jail detainees with age between 30-40 were more likely to abuse cocaine (OR = 8.6, CI = 3.5-23.2), heroin (OR = 4.7, CI = 1.2-23.7), and IDU (OR = 2.8, CI = 1.2-6.9). Younger males with age <30 were more likely to abuse marijuana (OR = 3.8, CI = 2.2-6.9) and had multiple sexual partners (OR = 2.1, CI = 1.2-3.8). African American were more likely to have multiple sexual partners (OR = 3.7, CI = 1.8-7.9), but less likely to engage in unprotected sex in last sexual encounter (OR = 0.3, CI = 0.1-0.6), with main partner (OR = 0.3, CI = 0.1-0.9) and non-main partner(s) (OR = 0.1, CI = 0.03-0.4). Having more than 7 prior incarcerations was predictive of heavy drinking (OR = 1.8, CI = 1.1-3.2), cocaine use (OR = 2.5, CI = 1.4-4.6), and IDU (OR = 2.9, CI = 1.1-7.7). Finishing high school was predictive of having less sexual partners (OR = 0.5, CI = 0.3-0.9) but more likely engaging in unprotected sex in last sexual encounter (OR = 3.3, CI = 1.6-7.2) and with main sexual partner (OR = 3.2, CI = 1.3-8.0).

Discussion

Our results indicate that males entering jail exhibit high rates of substance use and sexual risk behaviors that increase their risk of HIV and other infectious diseases. Our study adds to the existing literature by demonstrating high risk behaviors among incarcerated populations and by highlighting whether certain risk behaviors are more likely to be co-occurring thus compounding risk for HIV infection.

Particularly from our pairwise and multivariate analyses, we find that cocaine is co-occurring with several other risk behaviors including heroin use, injection drug use, and multiple sexual partners. Cocaine use has been reported to not only increase the probability of HIV transmission, but also the potential of poor health outcomes in those living with HIV infection [22,33-35]. Given that there is currently no pharmacotherapy based intervention for cocaine addiction as there is for opiate addiction, our study supports the need of developing behavior-based interventions for cocaine abuse that is appropriate for incarcerated populations in addition to addressing opiate use and risky sexual behaviors. Since jail incarcerations may be as short as several days, behavioral interventions such as contingency management (CM) [36-39] may provide immediate reinforcement for abstinence from cocaine use, and cognitive behavioral interventions that are paired with CM upon release may offer a bridge for continued abstinence following community re-entry [40]. However, these interventions have not been implemented among incarcerated populations [41].

The finding that unprotected sex with main partner is co-occurring with unprotected sex with non-main partner(s) is another important finding, as this suggests that some participants could be involved with concurrent sexual relationships. Concurrent sexual partnerships in incarcerated populations have been reported in several studies [42-46]. Further accounting for concurrent sexual partnerships (and social/sexual networks) in our analyses would strengthen our conclusions, but unfortunately as one limitation of this paper, collecting concurrent behaviors data is not a focus of our original study.

Heavy alcohol use and marijuana use are common substances used by this population and found to be mostly co-occurring. Previous findings with younger incarcerated men [47] suggested that prior to incarceration, the use of marijuana alone and alcohol alone increased the likelihood of multiple sexual partners (i.e. 3 or more) and when in used in combination, sexual HIV-risk behaviors and inconsistent condom use behaviors with female partners increased. Similar finding also can be found in [15,48]. Comparable to other drugs of abuse, alcohol and marijuana use can impair judgment thereby preventing safer sex behaviors, and hence remain an important domain for intervention.

This paper has several limitations. The risk behavior data were self-reported which might have introduced bias and possibly an underreporting of risk behaviors given the environment in which participants completed the questionnaire. Our findings are not generalizable to incarcerated women or the entire population, because it is known that incarcerated women have a different rate of HIV infection and other transmissible diseases compared to men. The study sample size is limited and study participants are restricted only to those at the RIDOC, which limits our analysis power to identify all co-occurring risk behaviors.

As the U.S. incarceration population continues to grow and disproportionate rates of HIV infection continue to rise among incarcerated individuals, the implications for intervention are important and imperative. Jails provide a unique opportunity for structural interventions for this high-risk population. The results of this study offer more insight into the risk behaviors of males entering the RIDOC jail, and elucidate the educational, counseling, and intervention needs of men at risk for HIV infection within the criminal justice system.

Sources of Funding Support

The research is supported by the Providence/Boston Center for AIDS Research (grant P30AI42853). Dr. Pinkston’s work is partially supported by a National Institute of Mental Health grant (5R01MH084757).

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

References

  1. Glaze L, Parks Correctional Populations in the United States, 2011. Retrieved Dec 12, 2012, from http: //bjs.ojp.usdoj.gov/content/pub/pdf/cpus11.pdf; 2012.
  2. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 US Dependent Areas—2010. HIV Surveillance Supplemental Report 2012;17(3): part A.
  3. Spaulding AC, Stephenson B, Macalino G, Ruby W, Clarke J, Flanigan T (2002) Human immunodeficiency virus in correctional facilities: A review. Clinical Infectious Diseases 35: 305–312.
  4. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM (2009) HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health PLoS One 4(11): e7558. [corssref]
  5. National Commission on Correctional Health Care. The health status of soon-to-be- released inmates: A report to Congress, Volumes 1 and 2. National Commission on Correctional Health Care; 2002, Chicago.
  6. Dean-Gaitor HD, Fleming PL (1999) Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996. AIDS 13: 2429–2435. [corssref]
  7. Hammett TM (1998) Public health/corrections collaborations: Prevention and treatment of HIV/AIDS, STDs, and TB. US Department of Justice, Office of Justice Programs, National Institute of Justice.
  8. Maruschak L. HIV in prisons, 2004. Retrieved March 6, 2009, from http: //www.ojp.usdoj.gov/bjs/pub/pdf/hivp04.pdf;
  9. Springer R (2004) Patient safety initiatives–correct site verification. Plast Surg Nurs 24(1): 6–7.
  10. Harrison P, Beck Prisoners in 2005. Washington, DC: Bureau of Justice Statistics, US Dept of Justice; 2006. NCJ publication 2006; 215092.
  11. Braithwaite R, Hammett T, Mayberry R. Prisons and AIDS: A public health challenge. New York: Jossey-Bass;
  12. Braithwaite R, Arriola K (2008) Male prisoners and HIV prevention: a call for action ignored. Am J Public Health 98(9 Suppl): S145–9. [corssref]
  13. Wohl AR, Johnson D, Jordan W, et al. (2000) High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr 24(4): 386–92.
  14. Conklin TJ, Lincoln T, Tuthill RW (2000) Self-reported health and prior health behaviors of newly admitted correctional inmates. Am J Public Health 90(12): 1939–41. [corssref]
  15. Altice FL, Mostashari F, Selwyn PA, et al. (1998) Predictors of HIV infection among newly sen- tenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol 18(5): 444–53.
  16. Stephenson BL, Wohl DA, McKaig R, et al. (2006) Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS 17(2): 103–8.
  17. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in cor- rectional populations: a review of epidemiology and AIDS 2005;19 Suppl 3: S41–6.
  18. Mertz KJ, Schwebke JR, Gaydos CA, Beidinger HA, Tulloch SD, Levine Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates. Sex Transm Dis 2002;29(5): 271–6.
  19. Chandler RK, Fletcher BW, Volkow ND (2009) Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA 301(2): 183– [corssref]
  20. Morrow KM. HIV, STD, and hepatitis risk behaviors of young men before and after incarceration. AIDS Care 2009;21(2): 235–43. [corssref]
  21. Milloy MJ, Buxton J, Wood E, Li K, Montaner JS, Kerr T (2009) Elevated HIV risk behavior among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health 9: 156.
  22. McCoy CB, Lai S, Metsch LR, Messiah SE, Zhao W (2004) Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV Ann Epidemiol 14(8): 535–42. [corssref]
  23. Shannon K, Rusch M, Morgan R, Oleson M, Kerr T, Tyndall MW. HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs. Subst Use Misuse 2008;43(3-4): 521–34.
  24. Effectiveness of interventions to address HIV in prisons. Geneva, Switzerland: World Health Organization 2007.
  25. Fazel S, Bains P, Doll H (2006) Substance abuse and dependence in prisoners: a systematic review. Addiction 101(2): 181–191. [corssref]
  26. Koulierakis G, Gnardellis C, Agrafiotis D, Power KG (2002) HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction 95(8): 1207–1216.
  27. HIV risk behavior before and after HIV counseling and testing in jail: a pilot study. J Acquir Immune Defic Syndr 2009;53(4): 485–90.
  28. Rubin DB. Inference and missing data (with discussion). Biometrika 1976;63: 581–592.
  29. Little RJA, Rubin DB. Statistical Analysis with Missing Data 2nd ed. Hoboken, NJ: John Wiley & Sons; 2002.
  30. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Malden, MA: Blackwell; 2002.
  31. Microsoft Access (2003). Microsoft Co (www.microsoft.com); 2003.
  32. R Development Core R: A Language and Environment for Statistical Computing. Vienna, Austria; 2010. ISBN 3-900051-07-0.
  33. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 2003;80(4 Suppl 3): iii7–14. [corssref]
  34. Moore J, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Mayer Longitudinal study of condom use patterns among women with or at risk for HIV. AIDS and Behavior 2001;5: 263–273.
  35. Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD (2006) Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 163(5): 412–20. [corssref]
  36. Petry NM, Alessi SM, Hanson T (2007) Contingency management improves abstinence and quality of life in cocaine abusers. J Consult Clin Psychol 75(2): 307–15. [corssref]
  37. Rash CJ, Alessi SM, Petry NM (2008) Contingency management is efficacious for cocaine abusers with prior treatment attempts. Exp Clin Psychopharmacol 16(6): 547–54. [corssref]
  38. Ledgerwood DM, Alessi SM, Hanson T, Godley MD, Petry NM (2008) Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics. J Appl Behav Anal 41(4): 517–26. [corssref]
  39. Petry NM, Barry D, Alessi SM, Rounsaville BJ, Carroll KM (2012) A randomized trial adapting contingency management targets based on initial abstinence status of cocaine- dependent patients. J Consult Clin Psychol 80(2): 276–85. [corssref]
  40. Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL (2003) Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav 17(1): 73–82. [corssref]
  41. Polonsky S, Kerr S, Harris B, Gaiter J, Fichtner RR, Kennedy MG (1994) HIV prevention in prisons and jails: obstacles and opportunities. Public Health Rep 109(5): 615–25.
  42. Adimora AA, Schoenbach VJ, Martinson F, et al. (2004) Concurrent sexual partnerships among African Americans in the rural south. Annals of Epidemiology 14(3): 155–160. [corssref]
  43. Mumola C, Karberg Drug use and dependence, state and federal prisoners, 2004. Re- trieved March 6, 2009, from http: //www.ojp.usdoj.gov/bjs/pub/pdf/shsplj.pdf; 2006.
  44. Adimora AA, Schoenbach VJ, Martinson FEA, Donaldson KH, Stancil TR, Fullilove RE (2003) Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection. JAIDS 34(4): 423–429.
  45. Khan MR, Doherty IA, Schoenbach VJ, Taylor EM, Epperson MW, Adimora AA (2009) In- carceration and high-risk sex partnerships among men in the United States. J Urban Health 86(4): 584–601. [corssref]
  46. Manhart LE, Aral SO, Holmes KK, Foxman B (2002) Sex partner concurrency: measurement, prevalence, and correlates among urban 18-39-year-olds. Sexually Transmitted Diseases 29(3): 133–143.
  47. Valera P, Epperson M, Daniels J, Ramaswamy M, Freudenberg N (2009) Substance use and HIV-risk behaviors among young men involved in the criminal justice system. The American Journal of Drug and Alcohol Abuse 35(1): 43–47.
  48. Edlin BR, Irwin KL, Faruque S, et al. (1994) Intersecting epidemics–crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine 331(21): 1422–1427.

Smaller and Small: Strategies to Iterate to Knowledge about the Granular Aspects of Donations

Abstract

The paper presents the use of an emerging science, Mind Genomics, to understand a practical aspect of daily life: what motivates a person to donate to a specific charity. Beyond the knowledge of specific messages which are deemed to be potentially effective as a stimulus to donation, the paper shows how knowledge of a specific end-use can inform us about the mind of a person for a more general problem—how understanding the messages for donation drives a deeper understanding of human motivation. The paper moves from inexpensive pilot tests, through an affordable experiment, and onto the creation of a tool to assign new people worldwide to the proper groups, so they can receive the appropriately targeted messages.

Introduction

Knowing What to Say to Donors to Encourage Giving

In today’s world, departments of development for various organizations have become increasingly important and active. One is inundated daily by requests for donations for all sorts of causes, ranging from simple letters from individuals to sophisticated outreach including brochures and other presentations with information intended to tap one’s emotions and open one’s wallets. Most appeals from organizations appear to be ‘on point,’ with the proper phrases, the proper images, and so forth [1-3].

Approaches to Science – Idiographic versus Nomothetic

Today’s culture of science drives research towards large samples and well-defined stimuli. Despite the fact that a great deal of science is exploratory, the majority of studies published would have us believe that the studies are following the hallowed dicta of philosopher of science Karl Popper, invoking the hypothetico-deductive system, creating a hypothesis, and then falsifying it. The editors of major journals look for breakthrough work, combining a robust combination of novelty and familiarity. Such work is not common, although it occasionally surfaces. The evolving culture of science focuses on extensions of today’s state of knowledge as represented in the existing scientific literature. The typical phrase is ‘plugging holes in the literature,’ or ‘answer a call from the literature.’ Scientific rigor is as much rigorous statistics as rigorous thinking. The published work must convince by virtue of statistical differences, not by daring challenges which advance science. Despite what is promoted as scientific ‘doctrine,’ today’s scientific world frowns upon these new directions, however, when the content of journals and the reactions of reviewers are studied in detail. A quandary arises when the research is meant to explore a topic rigorously with good underlying design but with affordable samples, with the goal to be used for practical ends while truly adding to knowledge of a topic. Can this effort be called science? Typically, these problems emerge in the social and behavioral sciences, but less frequently in the harder sciences.

The focus of this paper is how one can quickly, inexpensively, and rigorously uncover the nature of the donor’s mind for a specific end recipient, that recipient being Children’s Cancer Center (name disguised to preserve confidentiality). The objective is to support children with cancer by addressing their medical, social, and psychological needs, as well as their family’s challenges. The problem is to discover what type of messages are likely to drive a person to donate. The problem is a practical one with a limited scope, specifically Children’s Cancer Center’s donations, but the learning which emerges from the study is relevant to an understanding of other communications driving support for a given charity. The empirical part of this paper shows the two steps followed to discover what to say to potential donors about Children’s Cancer Center. The combination of the two studies may be viewed as a discussion of ‘method,’ so-called methodological research. The specific findings of the second study, which is larger, but still small in terms of general practice, show what can be discovered for practical use.

About Children’s Cancer Center

Data from the World Health Organization (WHO) and the National Cancer Institute reveal that, in the United States, cancer is the leading cause of death by disease past infancy and will lead to the deaths of approximately 1,190 children in the U.S. in 2021. Further, As of January, 2015, the most recent data readily available, The National Cancer Institute reports that there are 429,000 survivors of childhood and adolescent cancer (diagnosed at ages 0 to 19 years) alive in the United States, and these survivors face serious medical problems during and after the acute phase of their disease (National Cancer Institute, 2018, 2020) [4,5].

Childhood cancer is a global issue. According to St. Jude Children’s Research Hospital’s website, cancer is diagnosed each year in about 175,000 children ages 14. The World Health Organization reports that more than 300,000 new cases are diagnosed annually in children ages 0-19. The number of actual cases is probably greater, because children in low-income countries are not likely to be included as part of the count. As Alex’s Lemonade website points out, “globally, cancer stole 11.5 million years of healthy life away from children in 2017.” This is because of life years taken away from kids who die, as opposed to a 90-year-old adult who dies of cancer and has very few life years left (Alex’s Lemonade, 2020) [6].

Despite the global prevalence of childhood cancer and the death rates associated with it, now 80% survival rates for US children but only 20% globally, only 4% of US government funding in the cancer sector is directed towards pediatric cancers. This has been challenged by pediatric cancer activists for years. A 2015 article by Kristin Connor in the Washington Examiner sheds light on the logic behind why our government doesn’t increase funding for childhood cancer:

“…cancer research funds are driven by the number of people — of any age — who have the disease. And, of course, adults, with decades of exposures and behaviors, experience cancer in much greater numbers than young children. This approach therefore seems like the “democratic” way to distribute federal money. Yet it doesn’t do much for the more than 15,700 children diagnosed each year with cancer, and the more than 40,000 children undergoing cancer treatment each year all across the United States. But instead of looking at the number of annual diagnoses, perhaps we should consider the number of life-years potentially saved. For each child with cancer, on average, as many as 71 potential life years might be saved. That’s an important factor that is not being considered when funding allocation decisions are made.” [7].

Despite great progress in US survival rates (84% of children diagnosed with cancer are alive at least five years after diagnosis), 16% are still dying AND those who do survive for five years are not necessarily cured, and many of them suffer from long-term side effects from their illness and associated treatments. According to Alex’s Lemonade, “Children who were treated for cancer are twice as likely to suffer chronic health conditions later in life versus children without a history of cancer.”

Some reason for optimism comes from the WHO: “most childhood cancers can be cured with generic medicines and other forms of treatments including surgery and radiotherapy. Treatment of childhood cancer can be cost-effective in all income settings.” Early intervention is critical to improving pediatric cancer outcomes. The WHO also calls for childhood cancer data systems, which are “needed to drive continuous improvements in the quality of care, and to drive policy decisions.” Donating to organizations like Children’s Cancer Center supports those factors that will lead to improved outcomes around the world. With the WHO’s statement that “the most effective strategy to reduce the burden of cancer in children is to focus on a prompt, correct diagnosis followed by effective therapy,” supporting an organization like Children’s Cancer Center is critical to reducing death rates of children worldwide [8].

The Mind Genomics Approach

Mind Genomics is an emerging science with roots in experimental psychology, sociology, consumer research, and statistics, respectively. The objective of a Mind Genomics study is to understand the messages for a topic which drive a specific response, such as ‘Dislike/Like,’ ‘Not interested/Interested,’ ‘Will Not donate/ will donate,’ ‘Will pay a certain amount,’ ‘expected to feel a certain way,’ and so forth. The purview of Mind Genomics is everyday life and the expected decisions that people make when they are presented with messages about a specific, granular, situation, of the type that would confront them daily. The process of Mind Genomics, the intellectual underpinnings, the statistics, and business-relevant patents have been documented extensively, and need not be repeated in their specifics. The reader is directed to a representative list [9-11]. Mind Genomics grew out of the need to create a new vision of science, one studying the behavior of the everyday, from the viewpoint of experimentation, rather than observation. Anthropology already studied individual cultures and behaviors in depth, with recent efforts attempting to move from purely descriptive to quantitative [12]. Sociology already studies everyday behavior but does not conduct experiments, and looks for general rules in everyday behavior, rules which are ‘nomothetic,’ dealing with generalities. Social psychology moves more closely into the world of the mind but again deals with issues of nomos. Social psychology is not experimental, and while it may deal with ordinary daily behavior, it attempts to provide a broad sweep of the behavior of people, rather than focusing on the topic itself. The topic of the study is only a means to understand the person. In the above disciplines, researchers focus on the person, using the normal situation to understand the person.

In contrast to other disciplines, Mind Genomics focuses on the specifics of the situation, using the person and the rules of judgment to understand. Thus, the learning is about the specifics of daily life, and less so about the person himself or herself. Indeed, one might use the metaphor that Mind Genomics focuses on the situation, with the situation ‘illuminated’ through the lights of different sources. These ‘lights,’ these different forms of illumination, are the people. The ultimate objective of Mind Genomics is to create a ‘Wiki of daily experience,’ a virtual encyclopedia of daily life and the different aspects of that daily life, dimensionalized into specifics, with the data being the aspect and numbers representing the way the ordinary person feels about that specific, on some type of scale. The problem for the ‘project of science’ is what type of information is acceptable for science? That is, the project discussed has a specific objective. Does the fact that there is such an objective invalidate the science, simply because the results pertain to a specific end-user, the Children’s Cancer Center charity? Furthermore, are the results not ‘valid’ because the base size is low? Finally, what is the status of the preparatory study—a small preliminary study to identify whether there are messages which resonate? Do preparatory studies deserve a place in the research report, because they illustrate the way towards making the larger discovery, by one or a set of small, ‘trial’ experiments?

Illustrating the Process of Mind Genomics Applied to Donations

Mind Genomics has already been used to study the nature of effective communication for donations [10,13]. The objective of the study is to understand the most productive and effective way to communicate to a prospective donor to Children’s Cancer Center. The relevance of the topic, donation, and the relevance of Children’s Cancer Center in the world of charity organizations for children with cancer will become obvious from the review of today’s information about children and cancer. Thus, anything helping to understand WHAT to communicate, and to WHOM, can play a major role in the world of health care and fundraising. The ordinary process for understanding what to communicate does not invoke science, nor does it invoke foundational experiments bridging the world of science and application. The ordinary process might be either to select previous messages that ‘worked’ to drive donations, or perhaps to classify the prospective donors into different groups, based upon WHO they are, WHAT they have done in the past, or how they THINK about general topics. The short case presented here shows how a rigorous scientific approach to understand how the mind of the donor can be applied to situations where guidance is needed, rather than where one wishes to establish for a scientific proposition with reasonable certainty. The underlying world view is that even within the world of application, one can create knowledge which informs the greater science. In the case study presented here, we show how a small pair of studies, one with four respondents and a succeeding one with 50 respondents, informs the world of charitable donations, establishing patterns that can used later on as springboards either for more application or for theory building. We now move to the science of Mind Genomics, following the process, not so much to establish general rules, but rather to investigate a specific, defined situation: donation to Children’s Cancer Center Hospital. We follow a series of steps, whether the Mind Genomics study is designed to understand charitable donations in general, or to understand charitable donations to a specific cause.

Our presentation of the process shows the results from two iterations. The first iteration, with the very small base size of four respondents (n=4), will show how Mind Genomics extracts information at virtually the level of one or a few individuals, in a manner similar to the way the anthropologist or the consumer researcher extracts information from in-depth interviews with one or two people or from focus groups of three or more people. The second iteration will move on with a more quantitative study of the responses from 50 individuals, after building on the learning from the first iteration, changing some of the material, and then testing. It is important to note that the process need not be restricted to one small study followed by one larger one, but might comprise several small studies, until these sequences of ‘iterations’ provide the information which seem to be most appropriate to answer the applied question, and to provide the structured knowledge for a ‘wiki of the mind’ with respect to the topic.

Step 1: Choose a Topic

This step sounds simple, but it requires the researcher to focus on a specific topic. Choosing the specific topic is the start of critical thinking required by Mind Genomics, whether the topic is a general one of daily behavior (what makes a person donate to a charity?) or a specific one (what makes a person want to donate to Children’s Cancer Center Hospital?).

Step 2: Create Four Questions Which ‘Tell a Story,’ Pertaining to the Topic

The iterative nature of Mind Genomics ensures that the researcher need not worry that the questions are correct. Indeed, part of the underlying world view of Mind Genomics is that science should be exploratory.

Step 3: Create Four Answers to Each Question

Again, these answers need not be the correct answers. The ability to iterate, to run a number of these small experiments, generate data which guide the researcher to better questions and better answers.

Step 4: Select a Rating Scale

The rating scale can be 5, 7 or 9 points. The actual number of scale points is left to the discretion of the respondents, as is the rating scale. There is no right or wrong scale. The topic of questions and scales has been a focus of researchers for a century. The pragmatic side of Mind Genomics is that the scale should be simple. The scale for this type of question (not donate vs. donate) should be simple to understand, anchored at both ends. An odd number of scale points is easier to work with when there is the possibility of a neutral point.

Step 5: Launch the Study and Get the Results Fully Analyzed within 90 Minutes

The process obtains respondents through a panel service (Luc.id), with the Mind Genomics platform automatically analyzing the data and returning a complete report, the entire process typically taking less than one to one and a half hours.

Step 6: Present the Appropriate Vignettes to the Respondent, Vignettes Created for That Respondent by the Permuted Experimental Design

Record the rating on the anchored 1-9 scale, and record the response time (consideration time), operationally defined as the number of seconds from the appearance of the vignette on the screen to the actual rating assigned by the respondent. Each respondent evaluates the appropriate set of vignettes to constitute an experimental design, allowing subsequent powerful analyses. Each respondent evaluates a unique set of combinations of messages, so that across the set of respondents the evaluations cover many of the possible combinations, rather than covering a few combinations, but with precision. The learning will be in the stimuli, not in the precision of the measurement.

Step 7: Obtain Data Analyzable Both at the Level of the Individual and at the Level of the Group, Respectively

Each respondent evaluates a full experimental design, analyzable at the level of the individual respondent. For the design comprising four questions and four answers (elements), the design prescribes 24 combinations (vignettes). Each vignette comprises 2-4 elements, no more than one element or answer from any question. The design ensures that each element appears 5x, uncorrelated with any other element; The experimental design is maintained, but the combinations are changed according to a permutation scheme [14,15]. Thus, the combinations cover more of the ‘design space’ than the usual approach using experimental design. The underlying rationale is that it is more productive to test many possible combinations with underlying variability (noise) in each measurement than to limit oneself to a few combinations, measuring each point in the design with many replicate measures to average out the variation. In short, the argument by Mind Genomics is that knowledge emerges from scope with modest precision at each point (the big pattern emerges), rather than from precision with narrow scope. This is the key tenet of Mind Genomics: scope is better than precision, at least in the early explorations of a topic.

Step 8: Convert the Rating Scale in Two Ways

The first transformation is ‘Top 3’ defined as a transformed value of 0 when the original rating was 1-6, defined as 100 when the original was 7-9. The first transformation focuses on what ‘drives’ a person to select ‘donate.’ The second transformation is ‘Bot 3’ defined as a transformed value of 0 when the original rating was 4-9, defined as a transformed value of 100 when the original rating was 1-3. The second transformation focuses on what ‘drives’ a person to select ‘will not donate.’ To all transformed ratings a small random number was added (<10-5) to ensure variation in the transformed rating, and thus to ensure that the OLS (ordinary least-squares regression) will ‘work,’ and not ‘crash.’ OLS regression requires variation in the dependent variable. The addition of the small random number ensures that variation without materially affecting the results.

Step 9: Cluster the Individual Respondents Based Upon the Pattern of Their 16 Coefficients for Top3

The clustering is done using k-means clustering with the measure of distance being (1-Pearson Correlation), viz., [16]. The Pearson correlation coefficient shows the strength of a linear relation between two sets of measures. When the relation is perfectly linear, increases in one measure correspond to precise increase in the other measure. There is no scatter, the Pearson correlation is +1, and the distance is 0 (1-1=0). In contrast, when the relation is perfectly inverse, increases in one measure correspond to precise decreases in the other measure. Again, there is no scatter, the Pearson correlation is -1, and the distance is 2 (1–1=2). The clustering program generates two, and then three groups, called mind-sets, because the clusters represent groups who attend to the elements or messages in different ways. We select that cluster solution (the array of mind-sets) which tells the most obvious story (interpretable), and which comprises the smallest number of segments (mind-sets). For the data in this study, the three-mind-set solution was easier to understand.

Step 10: Create the Model for All Appropriate Data from the Respondents from Each Key Subgroup

Each group (Total, three Mind-Sets) generates three models or equation; Top3 (drivers of positive response), Bot3 (drivers of negative response), and RT (response time, or consideration time, measure of engagement with the material, whether the response to the element was positive or negative).

The model is a simple weighted, linear equation of the form:

Top3 (or Bot3) = ko + k1(A1) + k2(A2) … k16 (D4)

Response Time = k1(A1) + k2(A2) …. K16 (D4)

The additive constant k0, shows the estimated Top3 (or Bot3) response in the absence of elements. The additive constant can be thought of as a baseline response, or the underlying, fundamental likelihood of the respondent to ‘donate’ (Top3) or ‘not donate’ (Bot3). The additive constant is not meaningful for response time RT, since in the absence of elements there is nothing to which one can respond.

Step 11: Assign a New Person to One of the Mind-sets by Means of a Short Questionnaire, the PVI, Personal Viewpoint Identifier

The PVI assigns a NEW person to one of the mind-sets, and by so doing expands the scope of the small-scale studies to practical use, whether to create a more effective campaign (application), or to understand the distribution and possibly nature of the people in the different mind-sets. This adds to our general knowledge of the minds of people regarding messages relevant to donations (science).

Results

The Two Studies

To illustrate the value of small studies and what can be learned with a sequential approach requiring 2-3 days, we present the results of two studies designed to understand what messages may work for a campaign. The project deals with messaging to drive donations for Children’s Cancer Center, a hospital devoted to pediatric cancer (name of actual hospital disguised to maintain confidentiality). To make the topic general, the actual study was conducted among the general population to uncover the messages which would appeal the general population, not simply appeal to previous donors to Children’s Cancer Center.

The knowledge development was done in two phases. The first phase, or experiment, can be considered a pilot study with 10 respondents, sufficient to provide deep insights. The key difference between a pilot study of 10 respondents and a larger scale study of 40-50 respondents, or even a much larger scale study of 100-200 respondents, is simply the ability to identify different groups in the population and study the pattern of their responses.

Study 1: Preliminary Learning through a ‘Mini-Study’

As noted above, the Mind Genomics project begins with the topic (donating to Children’s Cancer Center specifically, or a cancer hospital for children in general). The next step requires the researcher to formulate the four questions that ‘tell a story.’ The questions emerging from the initial discussion tell such a story. They may not be the only questions, but in an exploratory study the objective is to learn just ‘what works.’ The four questions are:

A. Question A: What is it like to be a pediatric cancer patient?

B. Question B: Why is it important to support Children’s Cancer Center?

C. Question C: What are the outcomes for children when you donate?

D. Question D: How do you give your donation?

The study was executed with 10 respondents chosen from a large group of panel participants recruited by Luc.id, Inc., based in Louisiana, a provider of panel participants for on-line studies. Each respondent evaluated a different set of 24 vignettes, constructed according to Step 6 above. With as few as one respondent the Mind Genomics study generates meaningful data, readable at the level of that single respondent. With 10 respondents, and occasionally even as few as three or four, patterns rapidly emerge, patterns which are relevant for the respondents, but which may or may not be projectible to the population at large.

Table 1 shows the coefficients for the response time, the positive coefficients for the positive responses (I will donate), and the positive coefficients for the negative responses (I will not donate).

Table 1: The four questions, four answers to each question and the coefficients from the grand model relating the 16 elements to the binary transformed rating. To help the underlying patterns emerge, only the positive, non-zero, coefficients are shown for Top3 and for Bot3. The response times are shown for all elements, but only the response times of 1.1 seconds are shown, those driving ‘engagement’.

table 1

The response time gives a sense of the elements which most engage the respondent. Even with a small base size of 10 respondents, the data from the deconstruction of the ratings into the contribution of the elements gives a sense of the nature of elements that effectively engage. Those elements talk about the children, and survival. The elements may not ‘drive expected donations,’ but they do engage as shown by the long response time (consideration time). Moving on to the ratings, or more specifically the transformed ratings, Table 1 suggests that the additive constant, the proclivity to donate or not to donate ranges between 40 and 50. In the absence of elements which provide specific information, there is no dramatic drive to donate or not to donate, at least for these randomly chosen respondents. What is more important, however, is that among the 16 elements or, the messages, only two reach significance (coefficients of 8 or higher).

You can donate online with the click of your mouse!

Children’s Cancer Center freely shares their research and treatment protocols with hospitals around the world.

The two elements have little in common, suggesting that there is probably no single strong message. It is the nature of researchers to continue looking. These data suggest no ‘magic bullet.’ They do suggest that if there are any ‘magic bullets,’ they may be found in different mind-sets in the population, if such mind-sets can be identified. It is at this point that one can begin to formulate hypotheses about the psychology of donations. The hypothesis emerging here is that ‘painting a graphic word picture’ of the child will engage attention. The science of Mind Genomics has now enriched our thinking about the psychology of donations and generosity, suggesting that graphic design of the recipient is something to consider. The data suggest a further opportunity to understand the nature of the portrait being painted.

Study 2: Identifying the Underlying Structure of What Works for Donating to the Hospital

Study 1 constituted the first foray into the topic, executed with 10 respondents. Although 10 respondents are not often considered to be sufficient to establish results, a base of 10 respondents from one or two focus groups is acceptable when considered to be an exploratory step. Thus, we considered Study 1 to be exploratory, providing information in a disciplined way, but with simply too few respondents.

Here again are the questions from Study 1

Question A: What is it like to be a pediatric cancer patient?

Question B: Why is it important to support Children’s Cancer Center?

Question C: What are the outcomes for children when you donate?

Question D: How do you give your donation?

Based upon the patterns of responses, here are the four revised questions. The key change is Question D, and of course the text of the elements themselves.

Question A: What is it like to be a pediatric cancer patient (why would you want to help)?

Question B: Why is it important to support Children’s Cancer Center?

Question C: What are the outcomes for children when you donate?

Question D: What would inspire you to give?

The second study was conducted with 50 respondents, of which the data from 48 respondents were retained. The remaining two respondents did not provide age or gender, and so their data were eliminated.

Table 2 shows the same type of data as does Table 1, this time for the new set of respondents, and the new set of elements. Once again, each respondent evaluated a unique set of 24 vignettes, constructed by experimental design, so that the data can be analyzed down to the level of the individual respondent. This strategy, so-called ‘within-subjects design’ ensures that the data can be further deconstructed into subgroups called ‘mind-sets,’ based upon the patterns of the coefficients for each respondent. At first glance, the data reaffirm the previous finding from Study #1 that there are no elements which strongly driving expected donations, when the topic is associated with Children’s Cancer Center. One might consider this a failure when the objective is to discover the so-called ‘magic bullet,’ the message that will work for everyone. The result might be the continued search for this ‘magic bullet’ in successive efforts, only to realize in the end that there is no ‘magic bullet,’ or if there is, no one has any idea about what specifically it is  and how to express it. At the practical level, the effort will be seen to have been wasted. There will be no science of communication about charitable contributions and how people feel. The unsatisfactory conclusion, soon to be discarded is ‘no business results, no contributions to the science of people, no additional knowledge for science of charity communications.’

Table 2: Results from the total panel from Study #2.

table 2

The picture changes, and significant learning for practical application and for foundational knowledge emerges, when one dives more deeply into Mind Genomics and discovers mind-sets. In Mind Genomics, the continuing data suggest the existence of what could be called mind-sets, different patterns of ideas which are interpretable in the form of a ‘story,’ patterns that seem to attach themselves to people. In the world of Mind-Genomics, considering people simply as ‘protoplasm which responds,’ there emerge groups of ideas which separately drive strong responses. People are the carriers of these ideas. People allow these groups of ideas to emerge. A person typically falls into a specific mind-set for a topic and not into the other mind-sets for the same topic. When we look at the data through the lens of mind-sets, using the computational process outlined in Steps 9 and 10 above and doing the computation on the Top3 (positive responses), we emerge with three new-to-the-world mind-sets, shown in Table 3 for Top3 (positive response – likely to donate), and in Table 4 for Bot3 (negative response – not likely to donate).

Table 3: Drivers of positive responses to messages, showing total panel, gender, and the three emergent mind-sets based on clustering using Top3.

table 3

To strengthen the scientific aspect of the results—the learning which is meant to be foundational rather than simply a direction for messaging to raise money—we include gender, as well, comparing the responses of males and females. Table 3 suggests three mind-sets. It is in the mind-sets that the strong elements emerge, elements with coefficients of +8 or higher.

a. There are some positive elements by gender, but no strong performers at all. Both male and female respondents are modestly interested in donating (additive constant=49)

b. Mind-Set 1 – Describe the professional services (modestly interested in donating at a basic level, additive constant=40)

c. Mind-Set 2 – Describe the person helped (modestly interested in donating at a basic level, additive constant=39)

d. Mind-Set 3 – Describe the institution’s performance (strongly interested in donating at a basic level, additive constant=69).

Table 4 shows the messages that should be avoided, the messages driving the response of ‘Not Donate.’ The coefficients emerge from considering only ratings of 1 and 2 as relevant on the 5-point scale, with ratings of 3-5 (neutral, will donate) as not relevant, and coded as 0. The additive constant is far lower for Not Donate than it is for Donate, meaning that people are more inclined to say that they will donate. Several messages to be used by the Center are likely to ‘backfire’, driving donors away. Mind-Set 2 is especially sensitive to the wrong messages.

Table 4: Drivers of negative responses to messages, showing total panel, gender, and the three emergent mind-sets based on clustering using Top3.

table 4

Finding these Respondents in the Population

A continuing topic in Mind Genomics is the value of a ‘next step’ beyond the already-important discovery of mind-sets. Mind-sets themselves provide a way of understanding daily life, through a new focus on the every-day and the way people differ in their typical behaviors. Yet, beyond the scientific contribution of knowledge is the remarkable potential of expanding the value of the learning, moving beyond the respondents tested in the study to the entire world. A simile is the colorimeter used to quantify colors of objects. The science of color can be developed in any location with any material. The real value of the science in terms of the ‘world outside’ is to measure the colors of new objects, not by repeating the study in which the colors were discovered, but rather by measuring the colors of the new objects using a machine in which the science has been already programmed [17-23]. The approach used in Mind Genomics is called the PVI, the personal viewpoint identifier. The objective is to use the data from Table 3 (MS1, MS2, MS3) to create a short questionnaire (six questions), on a simple to-use scale. The questions come from the actual study. The pattern of responses assigns a NEW PERSON to one of the three mind-sets. There are 64 possible patterns, each pattern mapping to one of the three mind-sets. Figure 1 shows the PVI, doing so in two parts. The left part is a short introduction, to introduce the person to the task, and to obtain optional background information. The right part is the actual PVI, including some basic questions about attitudes towards ‘giving’ and the six-question PVI. The results are forwarded to a database and can be sent to the respondents, as well.

fig 1

Figure 1: The PVI, personal viewpoint identifier, based upon the second study. The PVI is located at: https://www.pvi360.com/TypingToolPage.aspx?projectid=1261&userid=2018.

Discussion and Conclusion

The empirical results are simple to discover, just by looking at the table of elements and how the elements or messages drive interest in donating. The message used in requesting should be straightforward and focus on how the organization saves and changes lives for the better. The outcome of the organization’s work, and not the process, should be the main message. One should avoid directly focusing on needs and tax breaks, respectively. Although a minority of prospective donors will care about needs or tax advantages, most people say that they will contribute when they are suitably convinced by the cause and mission of the effort and in the vision detailing how their contribution can help. It is at this point that one can begin to formulate hypotheses about the psychology of donations. The hypothesis emerging here is that ‘painting a graphic word picture’ of the child will engage attention. The science of Mind Genomics has now enriched our thinking about the psychology of donations and generosity, suggesting that graphic design of the recipient is something to consider. The data suggest a further opportunity to understand the nature of the portrait being painted. It is not important to point out major ‘learnings’ from the results, learnings which confirm or disconfirm what is known in the literature, or what is hypothesized to be the case for the psychology of donors or the psychology of children with cancer. That information is, of course, important to know for science. What is more important, however, is the ability to have at one’s disposal a tool for small-scale, iterative experimentation: Mind Genomics, a tool which returns rich information even with remarkably small base sizes, such as n=10 or even fewer. In the world of science, Mind Genomics becomes a tool bridging the gap between the idiographic (individual) and the nomothetic (the general world). Just as important, Mind Genomics becomes both a practical tool to increase donations, as well as a tool for the development of systematized knowledge, both for the current generation and for those to come—a ‘wiki of the mind.’ Finally, viewed from the grand proscenium arch of civilization, Mind Genomics provides a record of how people of a certain time, in a specific environment, and faced with known needs, think about topics— a record of inestimable value to philosophy, psychology, history, sociology, anthropology, and economics, just to name a few disciplines where knowledge of the granular is important.

References

  1. Cao X, Jia L (2017) The effects of the facial expression of beneficiaries in charity appeals and psychological involvement on donation intentions: evidence from an online experiment. Nonprofit Management and Leadership 27: 457-473.
  2. Das N, Guha, A, Biswas A, Krishnan B (2016) How product–cause fit and donation quantifier interact in cause-related marketing (CRM) settings: Evidence of the cue congruency effect. Marketing Letters 27: 295-308.
  3. Mejova Y, Garimella VRK, Weber I, Dougal MC (2014) February. Giving is caring: understanding donation behavior through email. In Proceedings of the 17th ACM conference on Computer supported cooperative work & social computing pg: 1297-1307.
  4. Childhood Cancer Survivor Study: An Overview. (2018, September 27). The National Cancer Institute. https://www.cancer.gov/types/childhood-cancers/ccss
  5. Childhood Cancer. (2020, Nov 7). The National Cancer Institute. https://www.cancer.gov/types/childhood-cancers
  6. Alex’s Lemonade (2020) Global Childhood Cancer Facts: By the Numbers. (2020, Dec 7). Alex’s Lemonade. https://bit.ly/3a49Cpl
  7. Connor, K. (2015, May 25). Why childhood cancer research gets shortchanged. Washington Examiner. https://www.washingtonexaminer.com/why-childhood-cancer-research-gets-shortchanged.
  8. Jude’s Children Research Hospital, 2020 Childhood Cancer Facts. (2020, Dec 7). St. Jude Children’s Research Hospital. https://www.stjude.org/treatment/pediatric-oncology/childhood-cancer-facts.html .
  9. Gabay G, Moskowitz HR (2012) The algebra of health concerns: implications of consumer perception of health loss, illness and the breakdown of the health system on anxiety. International Journal of Consumer Studies 36: 635-646.
  10. Galanter E, Moskowitz H, Silcher M (2011) The Price of Grace: Donations, Charities, and the Mind. People, Preferences and Prices: Sequencing the Economic Genome of the Consumer Mind pg:103.
  11. Moskowitz HR, Gofman A (2007) Selling blue elephants: How to make great products that people want before they even know they want them. Pearson Education.
  12. Williams LL, Quave K (2019) Quantitative Anthropology, A workbook. Elsevier.
  13. Gabay G, Moskowitz H, Gere A (2019) September. UNDERSTANDING THE DONATING MIND & OPTIMIZING MESSAGING–PUBLIC HOSPITALS. In 12th Annual Conference of the EuroMed Academy of Business.
  14. Gofman A, Moskowitz H (2010a) Isomorphic permuted experimental designs and their application in conjoint analysis. Journal of Sensory Studies 25: 127-145.
  15. Moskowitz H, Gofman A, I novation Inc (2003) System and method for content optimization. U.S. Patent 6,662,215.
  16. Ramasubbareddy S, Srinivas TAS, Govinda K, Manivannan SS (2020) Comparative Study of Clustering Techniques in Market Segmentation. In Innovations in Computer Science and Engineering, pg: 117-125, Springer, Singapore.
  17. Gofman A, Moskowitz, HR (2010b) Improving customers targeting with short intervention testing. International Journal of Innovation Management, 14: 435-448.
  18. Global Initiative for Childhood Cancer. World Health Organization. (2020, December 7). https://www.who.int/cancer/childhood-cancer/en/
  19. Health Affairs, 2020. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.25.2.541
  20. Importance of CEO involvement in creating a culture of philanthropy in hospitals.
  21. Moskowitz HR, Gofman A, Innovation Inc, (2011). System and method for performing conjoint analysis. U.S. Patent 7,941,335.
  22. Notaro S (2020) https://bit.ly/3b7wBQi.
  23. Social Science Direct (2020) https://www.sciencedirect.com/science/article/abs/pii/S2213076415300051. Use of social media by US Children’s’ hospitals.